FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Tominaga, T
   Shimada, R
   Okada, Y
   Kawamata, T
   Kibayashi, K
AF Tominaga, Tadasuke
   Shimada, Ryo
   Okada, Yoshikazu
   Kawamata, Takakazu
   Kibayashi, Kazuhiko
TI Senescence-associated-beta-galactosidase staining following traumatic
   brain injury in the mouse cerebrum
SO PLOS ONE
LA English
DT Article
ID CELLULAR SENESCENCE; CYCLIN D1; EXPRESSION; INHIBITOR; INDUCTION;
   APOPTOSIS; CELLS; P16
AB Primary and secondary traumatic brain injury (TBI) can cause tissue damage by inducing cell death pathways including apoptosis, necroptosis, and autophagy. However, similar pathways can also lead to senescence. Senescent cells secrete senescence-associated secretory phenotype proteins following persistent DNA damage response signaling, leading to cell disorders. TBI initially activates the cell cycle followed by the subsequent triggering of senescence. This study aims to clarify how the mRNA and protein expression of different markers of cell cycle and senescence are modulated and switched over time after TBI. We performed senescence-associated-beta-galactosidase (SA-beta-gal) staining, immunohistochemical analysis, and real-time PCR to examine the time-dependent changes in expression levels of proteins and mRNA, related to cell cycle and cellular senescence markers, in the cerebrum during the initial 14 days after TBI using a mouse model of controlled cortical impact (CCI). Within the area adjacent to the cerebral contusion after TBI, the protein and/or mRNA expression levels of cell cycle markers were increased significantly until 4 days after injury and senescence markers were significantly increased at 4, 7, and 14 days after injury. Our findings suggested that TBI initially activated the cell cycle in neurons, astrocytes, and microglia within the area adjacent to the hemicerebrum contusion in TBI, whereas after 4 days, such cells could undergo senescence in a cell-type-dependent manner.
C1 [Tominaga, Tadasuke; Kawamata, Takakazu] Tokyo Womens Med Univ, Sch Med, Dept Neurosurg, Tokyo, Japan.
   [Shimada, Ryo; Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Tokyo, Japan.
   [Okada, Yoshikazu] St Lukes Int Hosp, Dept Neurosurg, Tokyo, Japan.
RP Shimada, R (reprint author), Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Tokyo, Japan.
EM r_shimada@twmu.ac.jp
RI Kazuhiko, Kibayashi/F-5173-2013
FU Japan Society for the Promotion of Science KAKENHI [JP16K09220]
FX This work was supported by the Japan Society for the Promotion of
   Science KAKENHI, Grant Number JP16K09220. The funder had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abdelalim EM, 2012, BIOCHEM BIOPH RES CO, V420, P605, DOI 10.1016/j.bbrc.2012.03.041
   Abe K, 2016, NEUROL RES, V38, P358, DOI 10.1080/01616412.2015.1110402
   Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2
   Cao X, 2015, GENOM PROTEOM BIOINF, V13, P333, DOI 10.1016/j.gpb.2015.11.002
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Delou JMA, 2016, AN ACAD BRAS CIENC, V88, P2257, DOI 10.1590/0001-3765201620160127
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ding Y, 2016, INT J BIOCHEM CELL B, V71, P72, DOI 10.1016/j.biocel.2015.12.010
   Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124
   Hwang CY, 2012, BIOCHEM BIOPH RES CO, V425, P94, DOI 10.1016/j.bbrc.2012.07.059
   Ishikawa K, 2015, FEBS J, V282, P2540, DOI 10.1111/febs.13298
   Johmura Y, 2014, MOL CELL, V55, P73, DOI 10.1016/j.molcel.2014.05.003
   Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165
   Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980
   Katano H, 2000, NEUROREPORT, V11, P2073, DOI 10.1097/00001756-200007140-00003
   Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481
   Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371
   Kochanek PM, 2001, J NEUROTRAUM, V18, P73, DOI 10.1089/089771501750055785
   Kozlova EN, 2002, GLIA, V37, P337, DOI 10.1002/glia.10045
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090
   Ohtani N., 2015, J CLIN EXPT MED, V253, P753
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X
   Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06
   Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7
   Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226
   Shimada R, 2017, LEGAL MED-TOKYO, V29, P29, DOI 10.1016/j.legalmed.2017.09.004
   Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289
   Shimada R, 2012, J CLIN NEUROSCI, V19, P447, DOI 10.1016/j.jocn.2011.06.033
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0
   Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243
   Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784
   Tsukamoto A, 2015, EXP ANIM TOKYO, V64, P57, DOI 10.1538/expanim.14-0050
   Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029
NR 38
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 11
PY 2019
VL 14
IS 3
AR e0213673
DI 10.1371/journal.pone.0213673
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HO6HL
UT WOS:000461030300058
PM 30856215
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Zhang, SQ
   Zeng, N
   Alowayed, N
   Singh, Y
   Cheng, AC
   Lang, F
   Salker, MS
AF Zhang, Shaqiu
   Zeng, Ni
   Alowayed, Nour
   Singh, Yogesh
   Cheng, Anchun
   Lang, Florian
   Salker, Madhuri S.
TI Downregulation of endometrial mesenchymal marker SUSD2 causes cell
   senescence and cell death in endometrial carcinoma cells
SO PLOS ONE
LA English
DT Article
ID DOMAIN-CONTAINING 2; STEM-CELLS; GROWTH-FACTOR;
   HEPATOCELLULAR-CARCINOMA; STEM/STROMAL CELLS; PROTEIN MODULE;
   CANCER-CELLS; GALECTIN-1; EXPRESSION; TUMORIGENESIS
AB The cause of death among the majority of endometrial cancer patients involves migration of cancer cells within the peritoneal cavity and subsequent implantation of cancer spheroids into neighbouring organs. It is, thereby, important to identify factors that mediate metastasis. Cell adhesion and migration are modified by the mesenchymal stem cell (MSC) marker Sushi domain containing 2 (SUSD2), a type I transmembrane protein that participates in the orchestration of cell adhesion and migration through interaction with its partner Galactosidase-binding soluble-1 (LGALS1). MSCs have emerged as attractive targets in cancer therapy. Human endometrial adenocarcinoma (Ishikawa) cells were treated with TGF beta (10 ng/ml) for 72h. SUSD2, LGALS1 and MKI67 transcript levels were quantified using qRT-PCR. The proportion of SUSD2 positive (SUSD2+) cells and SMAD2/3 abundance were quantified by FACS and Western blotting, respectively. Senescent cells were identified with beta-galactosidase staining; cell cycle and cell death were quantified using Propidium Iodide staining. Treatment of endometrial cancer cells (Ishikawa cells) with TGF beta (10 ng/ml) significantly decreased SUSD2 transcript levels and the proportion of SUSD2 positive cells. Silencing of SUSD2 using siRNA resulted in senescence and cell death of Ishikawa cells via activation of SMAD2/3. These findings suggest that SUSD2 counteracts senescence and cell death and is thus a potential chemotherapeutic target in human endometrial cancer.
C1 [Zhang, Shaqiu; Cheng, Anchun] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu, Sichuan, Peoples R China.
   [Zhang, Shaqiu; Zeng, Ni; Alowayed, Nour; Singh, Yogesh] Tubingen Univ, Dept Internal Med 3, Tubingen, Germany.
   [Singh, Yogesh] Tubingen Univ, Inst Med Genet & Appl Genom, Tubingen, Germany.
   [Lang, Florian; Salker, Madhuri S.] Tubingen Univ, Dept Physiol 1, Tubingen, Germany.
   [Salker, Madhuri S.] Univ Hosp Tubingen, Res Inst Womens Hlth, Tubingen, Germany.
RP Lang, F (reprint author), Tubingen Univ, Dept Physiol 1, Tubingen, Germany.
EM florian.lang@uni-tuebingen.de
RI Singh, Yogesh/T-8230-2017
OI Singh, Yogesh/0000-0001-6919-6273
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Burke W. M., 2014, GYNECOL ONCOL, V134, P385, DOI DOI 10.1016/J.YGYN0.2014.05.018
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cheng YY, 2016, TUMOR BIOL, V37, P9919, DOI 10.1007/s13277-015-4734-y
   Ciccarelli FD, 2002, TRENDS BIOCHEM SCI, V27, P113, DOI 10.1016/S0968-0004(01)02049-7
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9
   Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021
   Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051
   Gurung S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15042
   Horbelt D, 2012, INT J BIOCHEM CELL B, V44, P469, DOI 10.1016/j.biocel.2011.12.013
   Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853
   Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291
   Jeschke U, 2009, J HISTOCHEM CYTOCHEM, V57, P871, DOI 10.1369/jhc.2009.952085
   Kadoya T, 2005, CURR DRUG TARGETS, V6, P375, DOI 10.2174/1389450054022007
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713
   Letouzey V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127531
   Liu XR, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0286-5
   Luo K., 2017, COLD SPRING HARBOR P, V9
   Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Murakami K, 2014, ENDOCRINOLOGY, V155, P4542, DOI 10.1210/en.2014-1370
   NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T
   Pan W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06812
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rajaraman G, 2013, TISSUE ENG PART C-ME, V19, DOI [10.1089/ten.tec.2011.0718, 10.1089/ten.TEC.2011.0718]
   Salker MS, 2016, CELL PHYSIOL BIOCHEM, V39, P1295, DOI 10.1159/000447834
   Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Shany S, 2016, ANTICANCER RES, V36, P6225, DOI 10.21873/anticanres.11216
   Sheets JN, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.64
   Sivasubramaniyan K, 2013, STEM CELLS DEV, V22, P1944, DOI 10.1089/scd.2012.0584
   Su K, 2014, ACTA BIOMATER, V10, P5012, DOI 10.1016/j.actbio.2014.08.031
   Sugahara T, 2007, CANCER SCI, V98, P900, DOI 10.1111/j.1349-7006.2007.00466.x
   Sugahara T, 2007, CANCER SCI, V98, P909, DOI 10.1111/j.1349-7006.2007.00467.x
   Tian H, 2016, ONCOL REP, V36, P1361, DOI 10.3892/or.2016.4942
   Ulrich D, 2014, HUM REPROD, V29, P1895, DOI 10.1093/humrep/deu159
   Watson AP, 2013, MOL CANCER RES, V11, P74, DOI 10.1158/1541-7786.MCR-12-0501-T
   Wu JF, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-21
   Wu SQ, 2009, EXP CELL RES, V315, P3099, DOI 10.1016/j.yexcr.2009.09.009
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yagi Hiroshi, 2013, Frontiers in Genetics, V4, P261, DOI 10.3389/fgene.2013.00261
   Yu AL, 2010, INVEST OPHTH VIS SCI, V51, P5718, DOI 10.1167/iovs.10-5679
NR 52
TC 3
Z9 3
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 25
PY 2017
VL 12
IS 8
AR e0183681
DI 10.1371/journal.pone.0183681
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE7EP
UT WOS:000408370700050
PM 28841682
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU McDonald, JT
   Gao, XF
   Steber, C
   Breed, JL
   Pollock, C
   Ma, LL
   Hlatky, L
AF McDonald, J. Tyson
   Gao, Xuefeng
   Steber, Cole
   Breed, Jawon Lee
   Pollock, Caitlin
   Ma, Lili
   Hlatky, Lynn
TI Host mediated inflammatory influence on glioblastoma multiforme
   recurrence following high-dose ionizing radiation
SO PLOS ONE
LA English
DT Article
ID LARGE GENE LISTS; TEMOZOLOMIDE ERA; SURVIVAL; CELLS; RADIOTHERAPY;
   SENESCENCE; PHENOTYPE; EXPOSURE; GROWTH; BETA
AB Despite optimal clinical treatment, glioblastoma multiforme (GBM) inevitably recurs. Standard treatment of GBM, exposes patients to radiation which kills tumor cells, but also modulates the molecular fingerprint of any surviving tumor cells and the cross-talk between those cells and the host. Considerable investigation of short-term (hours to days) post-irradiation tumor cell response has been undertaken, yet long-term responses (weeks to months) which are potentially even more informative of recurrence, have been largely overlooked. To better understand the potential of these processes to reshape tumor regrowth, molecular studies in conjunction with in silico modeling were used to examine short- and long-term growth dynamics. Despite survival of 2.55% and 0.009% following 8 or 16Gy, GBM cell populations in vitro showed a robust escape from cellular extinction and a return to pre-irradiated growth rates with no changes in long-term population doublings. In contrast, these same irradiated GBM cell populations injected in vivo elicited tumors which displayed significantly suppressed growth rates compared to their pre-irradiated counterparts. Transcriptome analysis days to weeks after irradiation revealed, 281 differentially expressed genes with a robust increase for cytokines, histones and C-C or C-X-C motif chemokines in irradiated cells. Strikingly, this same inflammatory signature in vivo for IL1A, CXCL1, IL6 and IL8 was increased in xenografts months after irradiation. Computational modeling of tumor cell dynamics indicated a host-mediated negative pressure on the surviving cells was a source of inhibition consistent with the findings resulting in suppressed tumor growth. Thus, tumor cells surviving irradiation may shift the landscape of population doubling through inflammatory mediators interacting with the host in a way that impacts tumor recurrence and affects the efficacy of subsequent therapies. Clues to more effective therapies may lie in the development and use of pre-clinical models of post-treatment response to target the source of inflammatory mediators that significantly alter cellular dynamics and molecular pathways in the early stages of tumor recurrence.
C1 [McDonald, J. Tyson; Gao, Xuefeng; Steber, Cole; Breed, Jawon Lee; Pollock, Caitlin; Ma, Lili; Hlatky, Lynn] Ctr Canc Syst Biol, Boston, MA 02215 USA.
   [McDonald, J. Tyson] Hampton Univ, Canc Res Ctr, Hampton, VA 23668 USA.
   [Gao, Xuefeng] Shenzhen HRK Biotech Co Ltd, Shenzhen, Guangdong, Peoples R China.
RP McDonald, JT (reprint author), Ctr Canc Syst Biol, Boston, MA 02215 USA.; McDonald, JT (reprint author), Hampton Univ, Canc Res Ctr, Hampton, VA 23668 USA.
EM john.mcdonald@hamptonu.edu
OI McDonald, John/0000-0003-4300-6827
FU National Institutes of Health's National Cancer Institute Integrative
   Cancer Biology Program (ICBP) [1U54CA149233]; ICBP Summer Cancer
   Research Fellowship/Internship Program; NCI Summer Cancer Research
   Fellowship/Internship Education
FX This study was supported by the National Institutes of Health's National
   Cancer Institute Integrative Cancer Biology Program (ICBP, 1U54CA149233)
   to L.H.; the efforts of research fellows, J.L.B. and C.S., were
   generously supported by the ICBP Summer Cancer Research
   Fellowship/Internship Program. Shenzhen HRK Bio-tech provided support in
   the form of salaries for author Xuefeng Gao, but did not have any
   additional role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. The specific
   roles of these authors are articulated in the 'author contributions'
   section.; We would like to acknowledge the contributions of Betty
   Tarnowski of the NCI, along with Clare Lamont and Melissa Klumpar of
   CCSB, in facilitating the NCI Summer Cancer Research
   Fellowship/Internship Education and Outreach efforts under the NIH ICBP.
CR Beheshti A, 2015, CANCER RES, V75, P1134, DOI 10.1158/0008-5472.CAN-14-1053
   Blaylock Russell L, 2013, Surg Neurol Int, V4, P15, DOI 10.4103/2152-7806.106577
   Brush JM, 2009, INT J RADIAT BIOL, V85, P483, DOI 10.1080/09553000902883794
   Chan JL, 2002, J CLIN ONCOL, V20, P1635, DOI 10.1200/JCO.20.6.1635
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Darefsky AS, 2012, CANCER-AM CANCER SOC, V118, P2163, DOI 10.1002/cncr.26494
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Gao X, 2012, CANCER RES, V73, P1481, DOI DOI 10.1158/0008-5472.CAN-12-3429
   Gao XF, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00138
   Gao XF, 2014, STEM CELLS INT, DOI 10.1155/2014/249309
   Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546
   HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044
   McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196
   McDonald JT, 2014, INT J RADIAT BIOL, V90, P231, DOI 10.3109/09553002.2014.877175
   McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171
   Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984
   Nicklin MJH, 2002, GENOMICS, V79, P718, DOI 10.1006/geno.2002.6751
   Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Roninson IB, 2003, CANCER RES, V63, P2705
   Segerstrom L, 2008, INT J ONCOL, V33, P341, DOI 10.3892/ijo_00000014
   Sen E, 2011, DRUG DISCOV TODAY, V16, P1044, DOI 10.1016/j.drudis.2011.09.003
   Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6
   Sintupisut N, 2013, NUCL ACIDS RES
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Yeung YT, 2012, J NEURO-ONCOL, V109, P35, DOI 10.1007/s11060-012-0875-7
   Zhang M, 2011, CANCER RES, V71, P7155, DOI 10.1158/0008-5472.CAN-11-1212
NR 34
TC 0
Z9 0
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 22
PY 2017
VL 12
IS 5
AR e0178155
DI 10.1371/journal.pone.0178155
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV8UA
UT WOS:000402058400063
PM 28542439
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Sakaki, M
   Ebihara, Y
   Okamura, K
   Nakabayashi, K
   Igarashi, A
   Matsumoto, K
   Hata, K
   Kobayashi, Y
   Maehara, K
AF Sakaki, Mizuho
   Ebihara, Yukiko
   Okamura, Kohji
   Nakabayashi, Kazuhiko
   Igarashi, Arisa
   Matsumoto, Kenji
   Hata, Kenichiro
   Kobayashi, Yoshiro
   Maehara, Kayoko
TI Potential roles of DNA methylation in the initiation and establishment
   of replicative senescence revealed by array-based methylome and
   transcriptome analyses
SO PLOS ONE
LA English
DT Article
ID CELLULAR SENESCENCE; HETEROCHROMATIN FORMATION; HUMAN FIBROBLASTS;
   GENE-EXPRESSION; CELLS; DEMETHYLATION; P53; CANCER; PROTEINS; PATHWAY
AB Cellular senescence is classified into two groups: replicative and premature senescence. Gene expression and epigenetic changes are reported to differ between these two groups and cell types. Normal human diploid fibroblast TIG-3 cells have often been used in cellular senescence research; however, their epigenetic profiles are still not fully understood. To elucidate how cellular senescence is epigenetically regulated in TIG-3 cells, we analyzed the gene expression and DNA methylation profiles of three types of senescent cells, namely, replicatively senescent, ras-induced senescent (RIS), and non-permissive temperatureinduced senescent SVts8 cells, using gene expression and DNA methylation microarrays. The expression of genes involved in the cell cycle and immune response was commonly either down-or up-regulated in the three types of senescent cells, respectively. The altered DNA methylation patterns were observed in replicatively senescent cells, but not in prematurely senescent cells. Interestingly, hypomethylated CpG sites detected on non-CpG island regions ("open sea") were enriched in immune response-related genes that had non-CpG island promoters. The integrated analysis of gene expression and methylation in replicatively senescent cells demonstrated that differentially expressed 867 genes, including cell cycle-and immune response-related genes, were associated with DNA methylation changes in CpG sites close to the transcription start sites (TSSs). Furthermore, several miRNAs regulated in part through DNA methylation were found to affect the expression of their targeted genes. Taken together, these results indicate that the epigenetic changes of DNA methylation regulate the expression of a certain portion of genes and partly contribute to the introduction and establishment of replicative senescence.
C1 [Sakaki, Mizuho; Ebihara, Yukiko; Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan.
   [Sakaki, Mizuho; Kobayashi, Yoshiro] Toho Univ, Grad Sch Sci, Dept Biomol Sci, Funabashi, Chiba, Japan.
   [Okamura, Kohji] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Setagaya Ku, Tokyo, Japan.
   [Igarashi, Arisa; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Setagaya Ku, Tokyo, Japan.
   [Maehara, Kayoko] Kio Univ, Grad Sch Hlth Sci, Dept Nutr, Nara, Japan.
RP Maehara, K (reprint author), Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan.
EM sakaki-m@ncchd.go.jp; yoshiro@biomol.sci.toho-u.ac.jp;
   k.maehara@kio.ac.jp
FU Takeda Science Foundation; Kio University; National Research Institute
   for Child Health and Development [24-3]; JSPS [15K19439]
FX This work was supported by the Takeda Science Foundation
   (http://www.takeda-sci.or.jp/) to KMae, a grant from Kio University
   (http://www.kio.ac.jp/) to KMae, grant 24-3 from the National Research
   Institute for Child Health and Development to KN and KMat, and
   Grant-in-Aid for Young Scientists (B 15K19439) from JSPS KAKENHI to AI.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Asada K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/17142
   Asuthkar S, 2012, ONCOTARGET, V3, P1439
   Ayala-Ortega E, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2273-6
   Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005
   BAUMANN H, 1991, J BIOL CHEM, V266, P20424
   Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007
   Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]
   Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745
   Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286
   Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602
   Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509
   Disayabutr S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158367
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672
   Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407
   Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97
   Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005
   Jjingo D, 2012, ONCOTARGET, V3, P462
   Kaneda A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002359
   Koch CM, 2013, METHODS MOL BIOL, V1048, P309, DOI 10.1007/978-1-62703-556-9_20
   Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003
   Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.253658100
   Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200
   Li CW, 2016, ONCOTARGET, V7, P8556, DOI 10.18632/oncotarget.7388
   Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Oliveira NFP, 2009, J CLIN PERIODONTOL, V36, P719, DOI 10.1111/j.1600-051X.2009.01446.x
   Overhoff MG, 2014, NUCLEIC ACIDS RES, V42, P1606, DOI 10.1093/nar/gkt1096
   Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589
   Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225
   Price ME, 2013, EPIGENETICS CHROMATI, V6, P4
   ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281
   Rusiecki JA, 2013, FRONT PSYCHIATRY, V4, P1
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113
   Taguchi YH, 2012, AGING DIS, V3, P301
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018
   Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104
   Truong TP, 2015, J CLIN EXP HEMATOP, V55, P1, DOI 10.3960/jslrt.55.1
   TSUYAMA N, 1991, CELL STRUCT FUNCT, V16, P55, DOI 10.1247/csf.16.55
   Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142
   van der Horst GTJ, 1999, NATURE, V398, P627
   Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112
   Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106
   Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1042/jcs.03293
   Weber AR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10806
   Wiehle L, 2016, MOL CELL BIOL, V36, P452, DOI 10.1128/MCB.00587-15
   Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233
   Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950
   Wu Z, 2015, J IMMUNOL RES, DOI 10.1155/2015/471342
   Yin HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep18824
   Zhang WJ, 2014, FREE RADICAL RES, V48, P550, DOI 10.3109/10715762.2014.893580
   Zhang ZH, 2016, IEEE PHOTONICS J, V8, DOI 10.1109/JPHOT.2016.2628205
NR 69
TC 8
Z9 8
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 3
PY 2017
VL 12
IS 2
AR e0171431
DI 10.1371/journal.pone.0171431
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN7DG
UT WOS:000396161700079
PM 28158250
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Marthandan, S
   Baumgart, M
   Priebe, S
   Groth, M
   Schaer, J
   Kaether, C
   Guthke, R
   Cellerino, A
   Platzer, M
   Diekmann, S
   Hemmerich, P
AF Marthandan, S.
   Baumgart, M.
   Priebe, S.
   Groth, M.
   Schaer, J.
   Kaether, C.
   Guthke, R.
   Cellerino, A.
   Platzer, M.
   Diekmann, S.
   Hemmerich, P.
TI Conserved Senescence Associated Genes and Pathways in Primary Human
   Fibroblasts Detected by RNA-Seq
SO PLOS ONE
LA English
DT Article
ID DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN-DIPLOID FIBROBLASTS; DNA-DAMAGE
   FOCI; CELLULAR SENESCENCE; REPLICATIVE SENESCENCE; TRANSCRIPTION FACTOR;
   PREMATURE SENESCENCE; OXIDATIVE STRESS; STRAND BREAKS; HUMAN-CELLS
AB Cellular senescence correlates with changes in the transcriptome. To obtain a complete view on senescence-associated transcription networks and pathways, we assessed by deep RNA sequencing the transcriptomes of five of the most commonly used laboratory strains of human fibroblasts during their transition into senescence. In a number of cases, we verified the RNA-seq data by real-time PCR. By determining cellular protein levels we observed that the age-related expression of most but not all genes is regulated at the transcriptional level. We found that 78% of the age-affected differentially expressed genes were commonly regulated in the same direction (either up- or down-regulated) in all five fibroblast strains, indicating a strong conservation of age-associated changes in the transcriptome. KEGG pathway analyses confirmed up-regulation of the senescence-associated secretory phenotype and down-regulation of DNA synthesis/repair and most cell cycle pathways common in all five cell strains. Newly identified senescence-induced pathways include up-regulation of endocytotic/phagocytic pathways and down-regulation of the mRNA metabolism and the mRNA splicing pathways. Our results provide an unprecedented comprehensive and deep view into the individual and common transcriptome and pathway changes during the transition into of senescence of five human fibroblast cell strains.
C1 [Marthandan, S.; Baumgart, M.; Groth, M.; Kaether, C.; Cellerino, A.; Platzer, M.; Diekmann, S.; Hemmerich, P.] Fritz Lipmann Inst eV FLI, Leibniz Inst Aging, Jena, Germany.
   [Priebe, S.; Schaer, J.; Guthke, R.] Hans Knoll Inst eV HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.
   [Cellerino, A.] Scuola Normale Super Pisa, Neurobiol Lab, Pisa, Italy.
RP Marthandan, S (reprint author), Fritz Lipmann Inst eV FLI, Leibniz Inst Aging, Jena, Germany.
EM smarthandan@fli-leibniz.de
RI Cellerino, Alessandro/M-9380-2013
OI Cellerino, Alessandro/0000-0003-3834-0097
FU German Ministry for Education and Research (Bundesministerium fur
   Bildung und Forschung - BMBF); Leibniz Association;  [0315581]
FX Funding was provided by grant No: 0315581, https://www.bmbf.de/en/. The
   work described here is part of the research program of the Jena Centre
   for Systems Biology of Ageing-JenAge. The authors acknowledge JenAge
   funding by the German Ministry for Education and Research
   (Bundesministerium fur Bildung und Forschung - BMBF). The publication of
   this article was funded by the Open Access fund of the Leibniz
   Association.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971
   Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   [Anonymous], 2008, R LANG ENV STAT COMP
   Baege AC, 2004, J VIROL, V78, P5720, DOI 10.1128/JVI.78.11.5720-5727.2004
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193
   Baumgart M, 2014, AGING CELL, V13, P965, DOI 10.1111/acel.12257
   Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799
   Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   Bertram MJ, 1999, MOL CELL BIOL, V19, P1479
   Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016
   Bonelli MA, 2001, EXP CELL RES, V267, P165, DOI 10.1006/excr.2001.5237
   Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519
   Campisi J, 2009, J GERONTOL A-BIOL, V64, P164, DOI 10.1093/gerona/gln073
   Chang ZF, 2001, J BIOMED SCI, V8, P176
   Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358
   Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392
   Chen JH, 2006, FEBS LETT, V580, P6669, DOI 10.1016/j.febslet.2006.11.023
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   Chin JH, 1996, AM J PHYSIOL-CELL PH, V271, pC362
   Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Cosme-Blanco W, 2008, EXP CELL RES, V314, P1973, DOI 10.1016/j.yexcr.2008.03.011
   Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010
   Cristofalo VJ, 1998, CRIT REV EUKAR GENE, V8, P43, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.30
   De Felice B, 2011, GENOMICS, V97, P265, DOI 10.1016/j.ygeno.2011.02.009
   Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Efferth T, 2003, AGEING RES REV, V2, P11, DOI 10.1016/S1568-1637(02)00046-6
   FEENEYBURNS L, 1983, T OPHTHAL SOC UK, V103, P416
   Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789
   Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991
   Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362
   FRIEDMAN HM, 1978, J CLIN MICROBIOL, V7, P368
   Gasnereau I, 2012, AM J PATHOL, V180, P131, DOI 10.1016/j.ajpath.2011.09.040
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259
   Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017
   Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200
   Hall PA, 2005, CLIN CANCER RES, V11, P6780, DOI 10.1158/1078-0432.CCR-05-0997
   Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392
   Hayashi N, 2008, PROSTATE, V68, P1283, DOI 10.1002/pros.20783
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Hjelmeland LM, 1999, INVEST OPHTH VIS SCI, V40, P1
   Holliday R, 2014, INTERD TOP GERONTOL, V39, P1, DOI 10.1159/000358896
   Honda S, 2001, INVEST OPHTH VIS SCI, V42, P2139
   Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003
   JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06
   Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2
   KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7
   Kauffmann A, 2010, GENOMICS, V95, P138, DOI 10.1016/j.ygeno.2010.01.003
   Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799
   Kikuchi N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-31
   Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280
   Kim N, 2013, CELL STRUCT FUNCT, V38, P21, DOI 10.1247/csf.12014
   Kim SJ, 2014, CELL DEATH DIFFER, V21, P1769, DOI 10.1038/cdd.2014.88
   Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087
   Klement K, 2012, MECH AGEING DEV, V133, P508, DOI 10.1016/j.mad.2012.06.003
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707
   Kronschnabl M, 2003, J GEN VIROL, V84, P61, DOI 10.1099/vir.0.18703-0
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kuo ML, 2012, SCI REP-UK, V2, DOI 10.1038/srep00822
   Lackner DH, 2014, AGING CELL, V13, P946, DOI 10.1111/acel.12234
   Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217
   Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825
   Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008
   Lin YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046807
   LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244
   Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002
   Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161
   Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307
   Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007
   Marthandan S, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0038-8
   Marthandan S, 2015, BIOMED RES INT, DOI 10.1155/2015/731938
   Marthandan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115597
   Matsunaga H, 1999, Mol Vis, V5, P39
   Matuoka K, 2003, ARCH GERONTOL GERIAT, V36, P203, DOI 10.1016/S0167-4943(02)00151-6
   Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277
   Michishita E, 1998, BIOCHEM BIOPH RES CO, V253, P667, DOI 10.1006/bbrc.1998.9832
   MILLIS AJT, 1992, EXP CELL RES, V201, P373, DOI 10.1016/0014-4827(92)90286-H
   Munch S, 2014, MOL CELL BIOL, V34, P1733, DOI 10.1128/MCB.01345-13
   Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460
   Nakamura AJ, 2009, AGING-US, V1, P212, DOI 10.18632/aging.100019
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063
   Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146
   Ors A, 2009, J BIOL CHEM, V284, P23989, DOI 10.1074/jbc.M109.018309
   Perez de Castro Ignacio, 2012, Genes Cancer, V3, P721, DOI 10.1177/1947601912473306
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174
   Sandhu C, 2000, ONCOGENE, V19, P5314, DOI 10.1038/sj.onc.1203908
   Schauble S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042150
   Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002
   Silva H, 2008, STEM CELL RES COMMUN
   Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802
   Sivakumar S, 2014, MOL BIOL CELL, V25, P594, DOI 10.1091/mbc.E13-07-0421
   Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Suzuki C, 2005, CANCER RES, V65, P11314, DOI 10.1158/0008-5472.CAN-05-1507
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   Tanaka H, 2000, NATURE, V404, P42
   Tao JQ, 2014, TUMOR BIOL, V35, P4389, DOI 10.1007/s13277-013-1578-1
   Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   TRLIFAJO.J, 1968, J HYG EPID MICROB IM, V12, P212
   Ueki T, 2009, CANCER RES, V69, P8752, DOI 10.1158/0008-5472.CAN-09-1809
   Vaughan S, 2011, AGING-US, V3, P913, DOI 10.18632/aging.100390
   Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003
   von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   Wagner M, 2001, EXP GERONTOL, V37, P41, DOI 10.1016/S0531-5565(01)00165-6
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wang JG, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0133-0
   Warrier S, 2014, CANCER GENE THER, V21, P381, DOI 10.1038/cgt.2014.42
   Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159
   Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002
   Yoshida Y, 2011, ANTICANCER RES, V31, P2535
   Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22
   Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013
   Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100
   Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644
   Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997
   Zuryn A, 2012, CELL BIOL INT, V36, P1129, DOI 10.1042/CBI20120274
NR 150
TC 16
Z9 16
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 3
PY 2016
VL 11
IS 5
AR e0154531
DI 10.1371/journal.pone.0154531
PG 31
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL5KK
UT WOS:000375675700039
PM 27140416
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Liu, Y
   Chen, LL
   Zhi, CC
   Shen, M
   Sun, WW
   Miao, DS
   Yuan, XQ
AF Liu, Yun
   Chen, Lulu
   Zhi, Chunchun
   Shen, Ming
   Sun, Weiwei
   Miao, Dengshun
   Yuan, Xiaoqin
TI 1,25(OH)(2)D-3 Deficiency Induces Colon Inflammation via Secretion of
   Senescence-Associated Inflammatory Cytokines
SO PLOS ONE
LA English
DT Article
ID VITAMIN-D-RECEPTOR; D ENDOCRINE SYSTEM; COLORECTAL-CANCER;
   CARCINOMA-CELLS; PHENOTYPE; RISK; DIFFERENTIATION; METABOLISM; PROMOTES;
   NETWORK
AB Epidemiological studies showed that 1,25-Dihydroxyvitamin D[1,25(OH)(2)D-3] insufficiency appears to be associated with aging and colon cancer while underlying biological mechanisms remain largely unknown. Inflammatory bowel disease is one of the risk factors for colon cancer. In this study, we investigated whether 1,25(OH)(2)D-3 deficiency has an impact on the colon of 25-hydroxyvitamin D 1 alpha-hydroxylase knockout [Cyp27b1(-/-]) mice fed on a rescue diet (high calcium, phosphate, and lactose) from weaning to 10 months of age. We found that 1,25(OH)(2)D-3 deficient mice displayed significant colon inflammation phenotypes including shortened colon length, thinned and disordered mucosal structure, and inflammatory cell infiltration. DNA damage, cellular senescence and the production of senescence-associated inflammatory cytokines were also increased significantly in the colon of Cyp27b1(-/-) mice. Furthermore, the levels of ROS in the colon were increased significantly, whereas the expression levels of antioxidative genes were down-regulated dramatically in the colon of Cyp27b1(-/-) mice. Taken together, our results demonstrated that 1,25(OH)(2)D-3 deficiency could induce colon inflammation, which may result from increased oxidative stress and DNA damage, subsequently, induced cell senescence and overproduction of senescence-associated secretory factors. Therefore, our findings suggest that 1,25(OH)(2)D-3 may play an important role in preventing the development and progression of colon inflammation and colon cancer.
C1 [Liu, Yun; Chen, Lulu; Zhi, Chunchun; Sun, Weiwei; Miao, Dengshun; Yuan, Xiaoqin] Nanjing Med Univ, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China.
   [Shen, Ming] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.
RP Yuan, XQ (reprint author), Nanjing Med Univ, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China.
EM yuanxq@njmu.edu.cn
FU National Natural Science Foundation of China [81201529, 81200431,
   81230009]
FX National Natural Science Foundation of China (81201529 to X Yuan,
   81200431 to W Sun and 81230009 to D Miao) http://www.nsfc.gov.cn/. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ananthakrishnan AN, 2012, GASTROENTEROLOGY, V142, P482, DOI 10.1053/j.gastro.2011.11.040
   BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257
   Cross HS, 2011, MOL CELL ENDOCRINOL, V347, P70, DOI 10.1016/j.mce.2011.07.022
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196
   DELUCA HF, 1973, NEW ENGL J MED, V289, P359
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Forster RE, 2011, BIOCHEM BIOPH RES CO, V414, P557, DOI 10.1016/j.bbrc.2011.09.117
   Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281
   Halicka HD, 2012, AGING-US, V4, P270, DOI 10.18632/aging.100450
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Holick MF, 1996, J NUTR, V126, pS1159
   Holick MF, 2011, J INVEST MED, V59, P872, DOI 10.2310/JIM.0b013e318214ea2d
   Hopkins MH, 2011, CANCER PREV RES, V4, P1645, DOI 10.1158/1940-6207.CAPR-11-0105
   Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011
   Huerta S, 2002, CANCER RES, V62, P741
   Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1
   Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111
   Lin R, 2002, MOL ENDOCRINOL, V16, P1243, DOI 10.1210/me.16.6.1243
   Liu N, 2008, ENDOCRINOLOGY, V149, P4799, DOI 10.1210/en.2008-0060
   Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209
   Lofano Katia, 2013, J Gastrointest Cancer, V44, P1, DOI 10.1007/s12029-012-9425-y
   Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   Meeker S, 2014, CANCER RES, V74, P4398, DOI 10.1158/0008-5472.CAN-13-2820
   Murillo G, 2005, J STEROID BIOCHEM, V97, P129, DOI 10.1016/j.jsbmb.2005.06.008
   Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252
   Nagai Taku, 2003, FASEB Journal, V17, P50
   Nakai K, 2014, AM J HYPERTENS, V27, P586, DOI 10.1093/ajh/hpt160
   Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027
   Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028
   Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Schutze N, 1999, BIOFACTORS, V10, P329, DOI 10.1002/biof.5520100403
   Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037
   Shen M, 2013, BONE, V55, P400, DOI 10.1016/j.bone.2013.04.015
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254
   Smith SM, 2005, J NUTR, V135, P437
   Tamez H, 2012, CURR OPIN NEPHROL HY, V21, P492, DOI 10.1097/MNH.0b013e3283557bf0
   Ting HJ, 2012, CANCER RES, V72, P958, DOI 10.1158/0008-5472.CAN-11-0042
   Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048
   van den Bergh Joop P W, 2011, Curr Osteoporos Rep, V9, P36, DOI 10.1007/s11914-010-0041-0
   Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048
   Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127
   Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321
NR 55
TC 6
Z9 6
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 20
PY 2016
VL 11
IS 1
AR e0146426
DI 10.1371/journal.pone.0146426
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DB5BW
UT WOS:000368529100031
PM 26790152
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Nishimatsu, H
   Suzuki, E
   Saito, Y
   Niimi, A
   Nomiya, A
   Fukuhara, H
   Kume, H
   Homma, Y
AF Nishimatsu, Hiroaki
   Suzuki, Etsu
   Saito, Yasuho
   Niimi, Aya
   Nomiya, Akira
   Fukuhara, Hiroshi
   Kume, Haruki
   Homma, Yukio
TI Senescent Cells Impair Erectile Function through Induction of
   Endothelial Dysfunction and Nerve Injury in Mice
SO PLOS ONE
LA English
DT Article
ID ADIPOSE-TISSUE; DIABETIC-RATS; HUMAN ATHEROSCLEROSIS; VASCULAR
   DYSFUNCTION; CORPUS CAVERNOSUM; GROWTH-FACTOR; NITRIC-OXIDE; DNA-DAMAGE;
   STEM-CELLS; TNF-ALPHA
AB Erectile dysfunction (ED) is a major health problem, particularly in the elderly population, which is rapidly increasing. It is necessary to elucidate the mechanism by which ED occurs in the elderly. Cellular senescence is commonly detected in old tissues, and it is well known that senescent cells not only withdraw from the cell cycle but also remain viable and actively produce a variety of cytokines. We examined the effect of senescent cells on erectile function after injection of senescent cells into the penises of mice. Human umbilical vein endothelial cells were infected with an adenovirus expressing a constitutively active mutant of Ras to induce senescence, and were injected into the penises of nude mice. These senescent cells expressed proinflammatory cytokines such as interleukin-1 beta (IL-1 beta). Injection of senescent cells impaired erectile function, as assessed by the measurement of intracavernous pressure. Although the structure of the cavernous body did not remarkably change, expression of the catalytically active form of endothelial nitric oxide synthase and that of total neural nitric oxide synthase significantly decreased after injection. The penises injected with the senescent cells expressed human IL-1 beta and subsequently endogenous proinflammatory cytokines such as mouse IL-1 beta and tumor necrosis factor-alpha. These results suggested that senescent cells impaired erectile function through induction of endothelial dysfunction and nerve injury. These effects may be mediated by proinflammatory cytokines produced by senescent cells.
C1 [Nishimatsu, Hiroaki; Saito, Yasuho; Niimi, Aya; Nomiya, Akira; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio] Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo 113, Japan.
   [Suzuki, Etsu] St Marianna Univ, Sch Med, Inst Med Sci, Miyamae Ku, Kawasaki, Kanagawa, Japan.
RP Suzuki, E (reprint author), St Marianna Univ, Sch Med, Inst Med Sci, Miyamae Ku, Kawasaki, Kanagawa, Japan.
EM esuzuki-tky@umin.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [24592422, 24592423]
FX This work was funded by Grants-in-Aid from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan to AN 24592422
   [http://www.jsps.go.jp]; and to HN 24592423 from Grants-in-Aid from the
   Ministry of Education, Culture, Sports, Science and Technology of Japan;
   [http://www.jsps.go.jp]. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/0000115118
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Batten P, 1996, IMMUNOLOGY, V87, P127
   BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6
   Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b
   BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9
   Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755
   Ferrini MG, 2007, BIOL REPROD, V76, P915, DOI 10.1095/biolreprod.106.059642
   FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168
   Fraga-Silva RA, 2013, J SEX MED, V10, P2430, DOI 10.1111/jsm.12262
   GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hedlund P, 1999, BRIT J PHARMACOL, V127, P349, DOI 10.1038/sj.bjp.0702556
   Huang YC, 2010, J SEX MED, V7, P1391, DOI 10.1111/j.1743-6109.2009.01697.x
   Khera M, 2011, J SEX MED, V8, P3204, DOI 10.1111/j.1743-6109.2011.02436.x
   Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3
   Labazi H, 2013, J SEX MED, V10, P2154, DOI 10.1111/jsm.12245
   Luttrell IP, 2008, AM J PHYSIOL-HEART C, V294, pH2204, DOI 10.1152/ajpheart.00027.2008
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.000023315.38086.bc
   Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22
   MULLARKEY CJ, 1990, BIOCHEM BIOPH RES CO, V173, P932, DOI 10.1016/S0006-291X(05)80875-7
   Nishimatsu H, 2013, J SEX MED, V10, P1707, DOI 10.1111/jsm.12177
   Nishimatsu H, 2012, J SEX MED, V9, P482, DOI 10.1111/j.1743-6109.2011.02469.x
   Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055
   Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694
   Pelleitier M, 1975, Methods Achiev Exp Pathol, V7, P149
   Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x
   Ryu JK, 2006, MOL THER, V13, P705, DOI 10.1016/j.ymthe.2005.10.016
   Seftel AD, 2004, J ANDROL, V25, P963
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shirai M, 2002, NIHON RINSHO, V60, P91
   Suzuki E, 2002, HYPERTENS RES, V25, P773
   Suzuki E, 2000, J BIOL CHEM, V275, P3637, DOI 10.1074/jbc.275.5.3637
   Suzuki E, 2013, SCI WORLD J, DOI 10.1155/2013/754735
   Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011
   Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607
   Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196
NR 42
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 20
PY 2015
VL 10
IS 4
AR UNSP e0124129
DI 10.1371/journal.pone.0124129
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG3XA
UT WOS:000353211700075
PM 25894557
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Hayakawa, T
   Iwai, M
   Aoki, S
   Takimoto, K
   Maruyama, M
   Maruyama, W
   Motoyama, N
AF Hayakawa, Tomohisa
   Iwai, Mika
   Aoki, Satoshi
   Takimoto, Koichi
   Maruyama, Mitsuo
   Maruyama, Wakako
   Motoyama, Noboru
TI SIRT1 Suppresses the Senescence-Associated Secretory Phenotype through
   Epigenetic Gene Regulation
SO PLOS ONE
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; HEMATOPOIETIC STEM-CELLS; NF-KAPPA-B;
   INDUCED PREMATURE SENESCENCE; EXTENDS LIFE-SPAN; CELLULAR SENESCENCE;
   TRANSCRIPTION FACTORS; HUMAN FIBROBLASTS; DAMAGE; STRESS
AB Senescent cells develop a pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). As many SASP components affect surrounding cells and alter their microenvironment, SASP may be a key phenomenon in linking cellular senesence with individual aging and age-related diseases. We herein demonstrated that the expression of Sirtuin1 (SIRT1) was decreased and the expression of SASP components was reciprocally increased during cellular senescence. The mRNAs and proteins of SASP components, such as IL-6 and IL-8, quickly accumulated in SIRT1-depleted cells, and the levels of these factors were also higher than those in control cells, indicating that SIRT1 negatively regulated the expression of SASP factors at the transcriptional level. SIRT1 bound to the promoter regions of IL-8 and IL-6, but dissociated from them during cellular senescence. The acetylation of Histone H3 (K9) and H4 (K16) of the IL-8 and IL-6 promoter regions gradually increased during cellular senescence. In SIRT1-depleted cells, the acetylation levels of these regions were already higher than those in control cells in the pre-senescent stage. Moreover, these acetylation levels in SIRT1-depleted cells were significantly higher than those in control cells during cellular senescence. These results suggest that SIRT1 repressed the expression of SASP factors through the deacetylation of histones in their promoter regions.
C1 [Hayakawa, Tomohisa; Iwai, Mika; Aoki, Satoshi; Maruyama, Wakako; Motoyama, Noboru] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Cognit Brain Sci, Obu, Aichi, Japan.
   [Hayakawa, Tomohisa; Maruyama, Mitsuo; Motoyama, Noboru] Nagoya Univ, Grad Sch Med, Dept Aging Res, Nagoya, Aichi 4648601, Japan.
   [Aoki, Satoshi; Takimoto, Koichi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 94021, Japan.
   [Maruyama, Mitsuo] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Mech Aging, Obu, Aichi, Japan.
RP Motoyama, N (reprint author), Natl Ctr Geriatr & Gerontol, Res Inst, Dept Cognit Brain Sci, Obu, Aichi, Japan.
EM motoyama@ncgg.go.jp
FU Japan Society for the Promotion of Science [KAKENHI 24590369]; Research
   Founding for Longevity Sciences from National Center for Geriatrics and
   Gerontology [23-1, 26-25]
FX This work was supported by the Japan Society for the Promotion of
   Science, KAKENHI 24590369 (to NM) and the Research Founding for
   Longevity Sciences 23-1 and 26-25 (to NM) from National Center for
   Geriatrics and Gerontology. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296
   Cao L, 2006, EMBO J, V25, P2167, DOI 10.1038/sj.emboj.7601115
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   de Magalhaes JP, 2002, FEBS LETT, V523, P157, DOI 10.1016/S0014-5793(02)02973-3
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200
   Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kobayashi Y, 2005, INT J MOL MED, V16, P237
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206
   Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Naka K, 2004, J BIOL CHEM, V279, P2030, DOI 10.1074/jbc.M309457200
   Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025
   Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487
   Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113
   Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013
   Sona Hubackova KK, 2014, AGING, V4, P932
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032
   Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
NR 55
TC 36
Z9 40
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 30
PY 2015
VL 10
IS 1
AR e0116480
DI 10.1371/journal.pone.0116480
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9HX
UT WOS:000350680700039
PM 25635860
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Bredeson, S
   Papaconstantinou, J
   Deford, JH
   Kechichian, T
   Syed, TA
   Saade, GR
   Menon, R
AF Bredeson, Sarah
   Papaconstantinou, John
   Deford, James H.
   Kechichian, Talar
   Syed, Tariq A.
   Saade, George R.
   Menon, Ramkumar
TI HMGB1 Promotes a p38MAPK Associated Non-Infectious Inflammatory Response
   Pathway in Human Fetal Membranes
SO PLOS ONE
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; GROUP BOX PROTEIN-1; PRETERM BIRTH; ALARMIN
   HMGB1; IN-VITRO; CYTOKINE; DNA; EXPRESSION; PHOSPHORYLATION; CELLS
AB Objective: Spontaneous preterm birth (PTB) and preterm prelabor rupture of membranes (pPROM) are major pregnancy complications often associated with a fetal inflammatory response. Biomolecular markers of this fetal inflammatory response to both infectious and non-infectious risk factors and their contribution to PTB and pPROM mechanism are still unclear. This study examined fetal membrane production, activation and mechanistic properties of high mobility group box 1 (HMGB1) as a contributor of the non-infectious fetal inflammatory response.
   Materials and Methods: HMGB1 transcripts and active HMGB1 were profiled in fetal membranes and amniotic fluids collected from PTB and normal term birth. In vitro, normal term not in labor fetal membranes were exposed to lipopolysaccharide (LPS) and water soluble cigarette smoke extract (CSE). HMGB1-transcripts and its protein concentrations were documented by RT-PCR and ELISA. Recombinant HMGB1 treated membranes and media were subjected to RT-PCR for HMGB1 receptors, mitogen activated protein kinase pathway analysis, cytokine levels, and Western blot for p38MAPK.
   Results: HMGB1 expression and its active forms were higher in PTB and pPROM than normal term membranes and amniotic fluid samples. Both LPS and CSE enhanced HMGB1 expression and release in vitro. Fetal membrane exposure to HMGB1 resulted in increased expression of TLR2 and 4 and dose-dependent activation of p38MAPK-mediated inflammation.
   Conclusions: HMGB1 increase by fetal membrane cells in response to either oxidative stress or infection can provide a positive feedback loop generating noninfectious inflammatory activation. Activation of p38MAPK by HMGB1 promotes development of the senescence phenotype and senescence associated sterile inflammation. HMGB1 activity is an important regulator of the fetal inflammatory response regardless of infection.
C1 [Bredeson, Sarah; Kechichian, Talar; Syed, Tariq A.; Saade, George R.; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA.
   [Papaconstantinou, John; Deford, James H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, NHLBI Prote Ctr Airway Inflammat, Galveston, TX 77555 USA.
   [Papaconstantinou, John; Deford, James H.] Univ Texas Med Branch, UTMB Biomol Resource Facil, Galveston, TX 77555 USA.
RP Menon, R (reprint author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA.
EM ra2menon@utmb.edu
FU dept of OB&GYN at The University of Texas Medical Branch at Galveston,
   Texas United States of America
FX Funding: The study is conducted using developmental funds provided to
   Dr. R. Menon by the dept of OB&GYN at The University of Texas Medical
   Branch at Galveston, Texas United States of America. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084
   Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565
   Bartling B, 2007, MOL NUTR FOOD RES, V51, P479, DOI 10.1002/mnfr.200600223
   Buhimschi CS, 2009, AM J PATHOL, V175, P958, DOI 10.2353/ajpath.2009.090156
   Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668
   Chen Y, 2013, RHEUMATOLOGY, V52, P1739, DOI 10.1093/rheumatology/ket134
   Ciucci A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023766
   Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dubicke A, 2010, J REPROD IMMUNOL, V84, P86, DOI 10.1016/j.jri.2009.09.010
   FORTUNATO SJ, 1994, AM J REPROD IMMUNOL, V32, P184, DOI 10.1111/j.1600-0897.1994.tb01112.x
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Gong HJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S10
   Guo ZS, 2013, AM J CANCER RES, V3, P1
   Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916
   Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222
   He ZW, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/596716
   Holmlund U, 2007, IMMUNOLOGY, V122, P430, DOI 10.1111/j.1365-2567.2007.02662.x
   Kalmes A, 1999, FEBS LETT, V444, P71, DOI 10.1016/S0014-5793(99)00034-4
   Kim SW, 2012, NEUROBIOL DIS, V46, P147, DOI 10.1016/j.nbd.2011.12.056
   Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395
   Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544
   Lee KB, 2000, J MOL BIOL, V304, P135, DOI 10.1006/jmbi.2000.4206
   Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015
   Menon R, 2014, AM J REPROD IMMUNOL, V72, P75, DOI 10.1111/aji.12220
   Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011
   Menon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083416
   Menon R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.027
   Menon R, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.051
   Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007
   Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390
   Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773
   Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296
   Romero R, 2012, J MATERN-FETAL NEO M, V25, P558, DOI 10.3109/14767058.2011.599083
   Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005
   Tang DL, 2011, ANTIOXID REDOX SIGN, V15, P2185, DOI 10.1089/ars.2010.3666
   Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014
   Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005
   Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648
   Zicari A, 2008, REPROD SCI, V15, P559, DOI 10.1177/1933719107312560
NR 46
TC 50
Z9 54
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 3
PY 2014
VL 9
IS 12
AR e113799
DI 10.1371/journal.pone.0113799
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA7WS
UT WOS:000349128700047
PM 25469638
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Di, GH
   Liu, Y
   Lu, Y
   Liu, J
   Wu, CT
   Duan, HF
AF Di, Guo-hu
   Liu, Yang
   Lu, Ying
   Liu, Jin
   Wu, Chutse
   Duan, Hai-Feng
TI IL-6 Secreted from Senescent Mesenchymal Stem Cells Promotes
   Proliferation and Migration of Breast Cancer Cells
SO PLOS ONE
LA English
DT Article
ID STROMAL CELLS; CELLULAR SENESCENCE; IN-VITRO; MARROW; GROWTH;
   DIFFERENTIATION; TRANSFORMATION; ADIPOGENESIS; METASTASIS; MODEL
AB Human mesenchymal stem cells (hMSCs) are currently investigated for a variety of therapeutic applications. However, MSCs isolated from primary tissue cannot meet clinical grade needs and should be expanded in vitro for several passages. Although hMSCs show low possibility for undergoing oncogenic transformation, they do, similar to other somatic cells, undergo cellular senescence and their therapeutic potential is diminished when cultured in vitro. However, the role of senescent MSCs in tumor progression remains largely elusive. In the current study, by establishing senescent human umbilical cord mesenchymal stem cells (s-UCMSCs) through the replicative senescence model and genotoxic stress induced premature senescence model, we show that s-UCMSCs significantly stimulate proliferation and migration of breast cancer cells in vitro and tumor progression in a co-transplant xenograft mouse model compared with 'young' counterparts (defined as MSCs at passage 5, in contrast to senescent MSCs at passage 45). In addition, we identified IL-6, a known pleiotropic cytokine, as a principal mediator for the tumor-promoting activity of s-UCMSCs by induction of STAT3 phosphorylation. Depletion of IL-6 from s-UCMSCs conditioned medium partially abrogated the stimulatory effect of s-UCMSCs on the proliferation and migration of breast tumor cells.
C1 [Di, Guo-hu; Liu, Yang; Liu, Jin; Wu, Chutse; Duan, Hai-Feng] BIRM, Beijing 100850, Peoples R China.
   [Lu, Ying] 307 Hosp, Beijing 100071, Peoples R China.
   [Di, Guo-hu] Shandong Acad Med Sci, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Shandong Eye Inst, Qingdao 266071, Peoples R China.
RP Duan, HF (reprint author), BIRM, 27 Taiping Rd, Beijing 100850, Peoples R China.
EM duanhf0720@163.com
FU National Basic Research and Development of China (973 program)
   [2010CB529903, 2010CB833600, 2012CB518105]; National Science Foundation
   of China [81201760, 30973670, 3090592]; Chinese National Science and
   Technology Major Project [2012ZX09102301-001, 2011ZX09102-001-30]
FX This work was supported by the National Basic Research and Development
   of China (973 program) (Nos. 2010CB529903, 2010CB833600 and
   2012CB518105); the National Science Foundation of China (Nos. 81201760,
   30973670 and 3090592); and the Chinese National Science and Technology
   Major Project (Nos. 2012ZX09102301-001 and 2011ZX09102-001-30). The
   funders had no role in study design, data collectin and analysis,
   decision to publish, or preparation of the manuscript.
CR Akiyama K, 2012, CELL STEM CELL
   Aldridge A, 2013, CYTOTHERAPY, V15, P89, DOI 10.1016/j.jcyt.2012.07.001
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002
   Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Di GH, 2012, CYTOTHERAPY, V14, P412, DOI 10.3109/14653249.2011.646044
   Di GH, 2012, J CELL PHYSIOL, V227, P879, DOI 10.1002/jcp.23066
   Duggal S, 2011, J CELL PHYSIOL, V226, P2908, DOI 10.1002/jcp.22637
   Efimenko A, 2014, STEM CELL TRANSL MED, V3, P32, DOI 10.5966/sctm.2013-0014
   Fecteau JF, 2013, BLOOD, V121, P971, DOI 10.1182/blood-2012-08-447813
   Gharibi B, 2012, STEM CELL TRANSL MED, V1, P771, DOI 10.5966/sctm.2010-0031
   Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254
   Gu ZF, 2012, CELL SIGNAL, V24, P2307, DOI 10.1016/j.cellsig.2012.07.012
   Han I, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt443
   Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188
   Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559
   Ko E, 2012, STEM CELLS DEV, V21, P1877, DOI 10.1089/scd.2011.0284
   Lawrenson K, 2010, NEOPLASIA, V12, P317, DOI 10.1593/neo.91948
   Li Y, 2011, J BONE MINER RES, V26, P2656, DOI 10.1002/jbmr.480
   Lisanti MP, 2011, CELL CYCLE, V10, P2059, DOI 10.4161/cc.10.13.16233
   Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020
   Sensebe L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt217
   Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197
   Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907
   Tian K, 2010, CELL PHYSIOL BIOCHEM, V26, P799, DOI 10.1159/000323973
   Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459
   Tsai K.S., 2011, GASTROENTEROLOGY
   Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130
   Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061366
NR 35
TC 35
Z9 36
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 24
PY 2014
VL 9
IS 11
AR e113572
DI 10.1371/journal.pone.0113572
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX2IM
UT WOS:000346766900049
PM 25419563
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Wansleeben, C
   Bowie, E
   Hotten, DF
   Yu, YRA
   Hogan, BLM
AF Wansleeben, Carolien
   Bowie, Emily
   Hotten, Danielle F.
   Yu, Yen-Rei A.
   Hogan, Brigid L. M.
TI Age-Related Changes in the Cellular Composition and Epithelial
   Organization of the Mouse Trachea
SO PLOS ONE
LA English
DT Article
ID IDIOPATHIC PULMONARY-FIBROSIS; LYMPHOID-TISSUE BALT; STEM-CELLS; INNATE
   IMMUNITY; BASAL-CELLS; LUNG; AIRWAY; MICE; SENESCENCE; HOMEOSTASIS
AB We report here senescent changes in the structure and organization of the mucociliary pseudostratified epithelium of the mouse trachea and main stem bronchi. We confirm previous reports of the gradual appearance of age-related, gland-like structures (ARGLS) in the submucosa, especially in the intercartilage regions and carina. Immunohistochemistry shows these structures contain ciliated and secretory cells and Krt5+ basal cells, but not the myoepithelial cells or ciliated ducts typical of normal submucosal glands. Data suggest they arise de novo by budding from the surface epithelium rather than by delayed growth of rudimentary or cryptic submucosal glands. In old mice the surface epithelium contains fewer cells per unit length than in young mice and the proportion of Krt5+, p63+ basal cells is reduced in both males and females. However, there appears to be no significant difference in the ability of basal stem cells isolated from individual young and old mice to form clonal tracheospheres in culture or in the ability of the epithelium to repair after damage by inhaled sulfur dioxide. Gene expression analysis by Affymetrix microarray and quantitative PCR, as well as immunohistochemistry and flow sorting studies, are consistent with low-grade chronic inflammation in the tracheas of old versus young mice and an increase in the number of immune cells. The significance of these changes for ARGL formation are not clear since several treatments that induce acute inflammation in young mice did not result in budding of the surface epithelium.
C1 [Wansleeben, Carolien; Bowie, Emily; Hogan, Brigid L. M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.
   [Hotten, Danielle F.; Yu, Yen-Rei A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
RP Hogan, BLM (reprint author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.
EM brigid.hogan@dm.duke.edu
FU National Institutes of Health [HL 4R37-HL07103-21]; Ellison Medical
   Foundation; American Lung Association [R225818-N]
FX Funding was from the National Institutes of Health (HL 4R37-HL07103-21
   to BLMH) and the Ellison Medical Foundation.
   (www.ellisonfoundation.org). CW was supported by an American Lung
   Association Fellowship R225818-N (www.lung.org). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Calvi CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020712
   Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112
   Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038
   ENGELHARDT JF, 1995, DEVELOPMENT, V121, P2031
   Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP
   Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121
   Giangreco A, 2011, J PATHOL, V224, P190, DOI 10.1002/path.2876
   HERNANDEZ JA, 1965, J AM GERIATR SOC, V13, P799, DOI 10.1111/j.1532-5415.1965.tb02060.x
   Huang JM, 2013, EXP GERONTOL, V48, P717, DOI 10.1016/j.exger.2013.04.001
   Ledford JG, 2009, J IMMUNOL, V182, P7818, DOI 10.4049/jimmunol.0900452
   Lucchetta EM, 2012, WIRES DEV BIOL, V1, P781, DOI 10.1002/wdev.51
   Madsen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064441
   Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447
   Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028
   MAYS PK, 1989, AM REV RESPIR DIS, V140, P410, DOI 10.1164/ajrccm/140.2.410
   Mollenhauer J, 2000, CANCER RES, V60, P1704
   Muller H, 2008, CLIN EXP IMMUNOL, V151, P123, DOI 10.1111/j.1365-2249.2007.03528.x
   NETTESHEIM P, 1970, JNCI-J NATL CANCER I, V44, P687
   O'Koren EG, 2013, AM J RESP CELL MOL, V49, P788, DOI 10.1165/rcmb.2012-0369OC
   PABST R, 1990, AM J RESP CELL MOL, V3, P131, DOI 10.1165/ajrcmb/3.2.131
   Paxson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023232
   Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629
   Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/B978-0-12-381300-8.00007-1, 10.1016/S0065-2776(10)07002-1]
   Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002
   Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031
   Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106
   Seiler C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001386
   Shaykhiev R, 2013, GERONTOLOGY, V59, P481, DOI 10.1159/000354173
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Shore SA, 2003, J APPL PHYSIOL, V95, P938, DOI 10.1152/japplphysiol.00336.2003
   Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777
   Wallace KN, 2005, DEV CELL, V8, P717, DOI 10.1016/j.devcel.2005.02.015
   Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434
   Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gast.2005.03.016
   Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172
   You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002
   Zeng N, 2013, AGING CELL
NR 42
TC 13
Z9 13
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 27
PY 2014
VL 9
IS 3
AR e93496
DI 10.1371/journal.pone.0093496
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE0SW
UT WOS:000333677500131
PM 24675804
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Secher, T
   Samba-Louaka, A
   Oswald, E
   Nougayrede, JP
AF Secher, Thomas
   Samba-Louaka, Ascel
   Oswald, Eric
   Nougayrede, Jean-Philippe
TI Escherichia coli Producing Colibactin Triggers Premature and
   Transmissible Senescence in Mammalian Cells
SO PLOS ONE
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; PERSISTENT DNA-DAMAGE; CELLULAR SENESCENCE;
   IN-VIVO; HETEROCHROMATIN FOCI; HUMAN FIBROBLASTS; OXIDATIVE STRESS;
   CANCER; EXPRESSION; PML
AB Cellular senescence is an irreversible state of proliferation arrest evoked by a myriad of stresses including oncogene activation, telomere shortening/dysfunction and genotoxic insults. It has been associated with tumor activation, immune suppression and aging, owing to the secretion of proinflammatory mediators. The bacterial genotoxin colibactin, encoded by the pks genomic island is frequently harboured by Escherichia coli strains of the B2 phylogenetic group. Mammalian cells exposed to live pks+ bacteria exhibit DNA-double strand breaks (DSB) and undergo cell-cycle arrest and death. Here we show that cells that survive the acute bacterial infection with pks+ E. coli display hallmarks of cellular senescence: chronic DSB, prolonged cell-cycle arrest, enhanced senescence-associated beta-galactosidase (SA-beta-Gal) activity, expansion of promyelocytic leukemia nuclear foci and senescence-associated heterochromatin foci. This was accompanied by reactive oxygen species production and pro-inflammatory cytokines, chemokines and proteases secretion. These mediators were able to trigger DSB and enhanced SA-beta-Gal activity in bystander recipient cells treated with conditioned medium from senescent cells. Furthermore, these senescent cells promoted the growth of human tumor cells. In conclusion, the present data demonstrated that the E. coli genotoxin colibactin induces cellular senescence and subsequently propel bystander genotoxic and oncogenic effects.
C1 [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] INRA, USC 1360, F-31931 Toulouse, France.
   [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] Fac Med Toulouse, INSERM, UMR 1043, F-31073 Toulouse, France.
   [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] CNRS, UMR 5282, Toulouse, France.
   [Secher, Thomas; Samba-Louaka, Ascel; Oswald, Eric; Nougayrede, Jean-Philippe] Univ Toulouse, UPS, CPTP, Toulouse, France.
   [Oswald, Eric] CHU Toulouse, Hop Purpan, Serv Bacteriol Hyg, Toulouse, France.
RP Nougayrede, JP (reprint author), INRA, USC 1360, F-31931 Toulouse, France.
EM jean-philippe.nougayrede@toulouse.inra.fr
RI SECHER, Thomas/P-4795-2016; Samba-Louaka, Ascel/H-7073-2016; Nougayrede,
   Jean-Philippe/I-6362-2019
OI Samba-Louaka, Ascel/0000-0003-4417-6254; Nougayrede,
   Jean-Philippe/0000-0002-6802-1890
FU French fondation ARC pour la recherche sur le cancer [SFI20101201751];
   Agence Nationale de la Recherche [ANR-10-CESA-0011, ANR-09-MIE-005];
   INRA [AO-blanc-2010]; conseil regional de Midi-Pyrenees [12050986]
FX This work was made possible by financial support SFI20101201751 from the
   French fondation ARC pour la recherche sur le cancer, by the Agence
   Nationale de la Recherche (ANR-10-CESA-0011) and grant AO-blanc-2010
   from INRA. Thomas Secher was supported by the Agence Nationale de la
   Recherche (ANR-09-MIE-005) and by the conseil regional de Midi-Pyrenees
   (12050986). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780
   Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Audebert M, 2010, TOXICOL LETT, V199, P182, DOI 10.1016/j.toxlet.2010.08.022
   Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277
   Blazkova H, 2010, J CELL MOL MED, V14, P357, DOI 10.1111/j.1582-4934.2009.00862.x
   Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj/onc/1205227
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Chen QM, 2000, J CELL SCI, V113, P4087
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dubois D, 2010, J CLIN MICROBIOL, V48, P2122, DOI 10.1128/JCM.02365-09
   Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1158/AEM.70.9.5698-5700.2004
   Ferbeyre G, 2000, GENE DEV, V14, P2015
   Frippiat C, 2000, EXP GERONTOL, V35, P733, DOI 10.1016/S0531-5565(00)00167-4
   Gordon DM, 2005, MICROBIOL-SGM, V151, P15, DOI 10.1099/mic.0.27425-0
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025
   Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08
   Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565
   Muller M, 2002, FREE RADICAL BIO MED, V33, P1527, DOI 10.1016/S0891-5849(02)01087-0
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059
   Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318
   Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011
   Ohtani S, 2004, MOL CANCER THER, V3, P93
   Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464
   Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x
   Pearson M, 2000, NATURE, V406, P207
   Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603
   Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x
   Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018
   Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002
   Varadaraj A, 2007, J PATHOL, V211, P471, DOI 10.1002/path.2126
   WANG X, 2013, CANCER PREV RES, V6, P971
   Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040
   Wang XM, 2012, GASTROENTEROLOGY, V142, P543, DOI 10.1053/j.gastro.2011.11.020
   Yang YH, 2012, CANCER RES, V72, P5219, DOI 10.1158/0008-5472.CAN-12-1463
   Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-62
   Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22
NR 69
TC 47
Z9 47
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 8
PY 2013
VL 8
IS 10
AR UNSP e77157
DI 10.1371/journal.pone.0077157
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 233FK
UT WOS:000325552200107
PM 24116215
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Florea, V
   Bhagavatula, N
   Simovic, G
   Macedo, FY
   Fock, RA
   Rodrigues, CO
AF Florea, Victoria
   Bhagavatula, Nithya
   Simovic, Gordana
   Macedo, Francisco Y.
   Fock, Ricardo A.
   Rodrigues, Claudia O.
TI c-Myc Is Essential to Prevent Endothelial Pro-Inflammatory Senescent
   Phenotype
SO PLOS ONE
LA English
DT Article
ID GROWTH-FACTOR MIDKINE; SMOOTH-MUSCLE-CELLS; TRANSCRIPTIONAL REPRESSION;
   OXIDATIVE STRESS; EXPRESSION; TL1A; ANGIOGENESIS; CYTOKINE; CYCLE; BETA
AB The proto-oncogene c-Myc is vital for vascular development and promotes tumor angiogenesis, but the mechanisms by which it controls blood vessel growth remain unclear. In the present work we investigated the effects of c-Myc knockdown in endothelial cell functions essential for angiogenesis to define its role in the vasculature. We provide the first evidence that reduction in c-Myc expression in endothelial cells leads to a pro-inflammatory senescent phenotype, features typically observed during vascular aging and pathologies associated with endothelial dysfunction. c-Myc knockdown in human umbilical vein endothelial cells using lentivirus expressing specific anti-c-Myc shRNA reduced proliferation and tube formation. These functional defects were associated with morphological changes, increase in senescence-associated-bgalactosidase activity, upregulation of cell cycle inhibitors and accumulation of c-Myc-deficient cells in G1-phase, indicating that c-Myc knockdown in endothelial cells induces senescence. Gene expression analysis of c-Myc-deficient endothelial cells showed that senescent phenotype was accompanied by significant upregulation of growth factors, adhesion molecules, extracellular-matrix components and remodeling proteins, and a cluster of pro-inflammatory mediators, which include Angptl4, Cxcl12, Mdk, Tgfb2 and Tnfsf15. At the peak of expression of these cytokines, transcription factors known to be involved in growth control (E2f1, Id1 and Myb) were downregulated, while those involved in inflammatory responses (RelB, Stat1, Stat2 and Stat4) were upregulated. Our results demonstrate a novel role for c-Myc in the prevention of vascular pro-inflammatory phenotype, supporting an important physiological function as a central regulator of inflammation and endothelial dysfunction.
C1 [Florea, Victoria; Bhagavatula, Nithya; Simovic, Gordana; Macedo, Francisco Y.; Fock, Ricardo A.; Rodrigues, Claudia O.] Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33152 USA.
   [Rodrigues, Claudia O.] Univ Miami, Leonard M Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL USA.
RP Rodrigues, CO (reprint author), Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33152 USA.
EM crodrigues@med.miami.edu
RI Fock, Ricardo/C-6105-2012
FU Florida Department of Health, James and Esther King Program [09KN-12];
   Florida Heart Institute; Brazilian National Research Council Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
FX This work was supported by the Florida Department of Health, James and
   Esther King Program (09KN-12), and Florida Heart Institute. R.A.F. was a
   fellow of the Brazilian National Research Council Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Al-Lamki RS, 2008, J AM SOC NEPHROL, V19, P953, DOI 10.1681/ASN.2007060706
   Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004
   Andersen DK, 2013, CURR OPIN ENDOCRINOL
   Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868
   Banno H, 2006, J VASC SURG, V44, P633, DOI 10.1016/j.jvs.2006.04.044
   Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7
   Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602
   Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c
   Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378
   Campaner S, 2010, CELL CYCLE, V9, P3655, DOI 10.4161/cc.9.18.13049
   Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004
   Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91
   Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697
   Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261
   Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   de Nigris F, 2000, CIRCULATION, V102, P2111, DOI 10.1161/01.CIR.102.17.2111
   de Nigris F, 2006, CELL CYCLE, V5, P1621, DOI 10.4161/cc.5.15.3138
   Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005
   Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010
   Erol A, 2011, CELL SIGNAL, V23, P1076, DOI 10.1016/j.cellsig.2010.11.023
   Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008
   Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213
   Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0
   Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835
   Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103
   Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447
   He C, 2008, DEVELOPMENT, V135, P2467, DOI 10.1242/dev.020131
   Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485
   Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002
   Hurley NE, 2010, J VASC RES, V47, P80, DOI 10.1159/000235928
   Kang YJ, 2005, CYTOKINE, V29, P229, DOI 10.1016/j.cyto.2004.12.001
   Kokai E, 2009, CIRC RES, V104, P1151, DOI 10.1161/CIRCRESAHA.108.191460
   Kosugi T, 2006, AM J PATHOL, V168, P9, DOI 10.2353/ajpath.2006.050488
   Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013
   Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X
   Lee MYK, 2010, J VASC RES, V47, P287, DOI 10.1159/000265563
   Li CX, 2002, CLIN HEMORHEOL MICRO, V26, P117
   Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145
   Lucas S, 2010, PEDIATR INT, V52, P75, DOI 10.1111/j.1442-200X.2009.02885.x
   Mallette FA, 2007, J BIOL CHEM, V282, P34938, DOI 10.1074/jbc.M707074200
   Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   MARIN ML, 1993, J VASC SURG, V18, P170, DOI 10.1016/0741-5214(93)90596-E
   Mazumder B, 2010, J IMMUNOL, V184, P3311, DOI 10.4049/jimmunol.0903778
   Meylan F, 2011, MUCOSAL IMMUNOL, V4, P172, DOI 10.1038/mi.2010.67
   Muck C, 2010, J GERONTOL A-BIOL, V65, P1165, DOI 10.1093/gerona/glq129
   Napoli C, 2002, NEOPLASIA, V4, P185, DOI 10.1038/sj/neo/7900232
   Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033
   Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364
   PARKES JL, 1991, AM J PATHOL, V138, P765
   Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3
   Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7
   Perdiguero EG, 2011, J BIOL CHEM, V286, P36841, DOI 10.1074/jbc.M111.220061
   Ramirez JA, 1996, J SURG RES, V61, P323, DOI 10.1006/jsre.1996.0124
   Rodrigues CO, 2008, DEVELOPMENT, V135, P1903, DOI 10.1242/dev.011296
   Sakamoto K, 2012, PATHOL INT, V62, P445, DOI 10.1111/j.1440-1827.2012.02815.x
   Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200
   Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076
   Stokes MB, 2005, THESCIENTIFICWORLDJO, V5, P828, DOI 10.1100/tsw.2005.106
   Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037
   Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519
   Taraban VY, 2011, MUCOSAL IMMUNOL, V4, P186, DOI 10.1038/mi.2010.70
   van der Horst E, 2008, NEOPLASIA, V10, P340, DOI 10.1593/neo.07820
   Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x
   WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788
   Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2
   Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011
   Weckbach LT, 2011, THESCIENTIFICWORLDJO, V11, P2491, DOI 10.1100/2011/517152
   Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141
   Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909
   Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38
   Zhai YF, 1999, FASEB J, V13, P181
   Zhang Z, 2012, CANC MICROENVIRON
NR 79
TC 12
Z9 12
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 6
PY 2013
VL 8
IS 9
AR e73146
DI 10.1371/journal.pone.0073146
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 224BO
UT WOS:000324856500036
PM 24039874
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Despars, G
   Carbonneau, CL
   Bardeau, P
   Coutu, DL
   Beausejour, CM
AF Despars, Genevieve
   Carbonneau, Cynthia L.
   Bardeau, Pascal
   Coutu, Daniel L.
   Beausejour, Christian M.
TI Loss of the Osteogenic Differentiation Potential during Senescence Is
   Limited to Bone Progenitor Cells and Is Dependent on p53
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; CELLULAR SENESCENCE; IONIZING-RADIATION;
   CHILDHOOD-CANCER; STROMAL CELLS; EXPRESSION; MICE; ACTIVATION;
   SURVIVORS; IRRADIATION
AB DNA damage can lead to the induction of cellular senescence. In particular, we showed that exposure to ionizing radiation (IR) leads to the senescence of bone marrow-derived multipotent stromal cells (MSC) and osteoblast-like stromal cells (OB-SC), a phenotype associated with bone loss. The mechanism by which IR leads to bone dysfunction is not fully understood. One possibility involves that DNA damage-induced senescence limits the regeneration of bone progenitor cells. Another possibility entails that bone dysfunction arises from the inability of accumulating senescent cells to fulfill their physiological function. Indeed, we show here that exposure to IR prevented the differentiation and mineralization functions of MSC, an effect we found was limited to this population as more differentiated OB-SC could still form mineralize nodules. This is in contrast to adipogenesis, which was inhibited in both IR-induced senescent MSC and 3T3-L1 pre-adipocytes. Furthermore, we demonstrate that IR-induced loss of osteogenic potential in MSC was p53-dependent, a phenotype that correlates with the inability to upregulate key osteogenic transcription factors. These results are the first to demonstrate that senescence impacts osteogenesis in a cell type dependent manner and suggest that the accumulation of senescent osteoblasts is unlikely to significantly contribute to bone dysfunction in a cell autonomous manner.
C1 [Despars, Genevieve; Carbonneau, Cynthia L.; Bardeau, Pascal; Beausejour, Christian M.] CHU St Justine, Ctr Rech, Montreal, PQ, Canada.
   [Despars, Genevieve; Carbonneau, Cynthia L.; Bardeau, Pascal; Beausejour, Christian M.] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.
   [Coutu, Daniel L.] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Stem Cell Dynam Res Unit, Munich, Germany.
RP Beausejour, CM (reprint author), CHU St Justine, Ctr Rech, Montreal, PQ, Canada.
EM christian.beausejour@recherche-ste-justine.qc.ca
OI Coutu, Daniel/0000-0002-4641-0115
FU Canadian Institute of Health Research [MOP-102709]; Fonds de la
   Recherche en Sante du Qubec (FRSQ); CIHR; FRQS
FX This work was supported by a grant from the Canadian Institute of Health
   Research (MOP-102709) (C.M.B.). G.D. has been supported by a student
   fellowship from the Fonds de la Recherche en Sante du Qubec (FRSQ.)
   C.L.C. and C.M.B. have been supported, respectively, by a student
   fellowship from the CIHR and a scientist award by the FRQS. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082
   Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   BROCKSTEDT H, 1993, BONE, V14, P681, DOI 10.1016/8756-3282(93)90092-O
   Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cao JJ, 2007, J BONE MINER RES, V22, P1271, DOI 10.1359/JBMR.070506
   Carbonneau CL, 2012, BLOOD, V119, P717, DOI 10.1182/blood-2011-06-361626
   Chen Q, 2012, J BONE MINER RES OFF
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x
   Kondo H, 2009, RADIAT RES, V171, P283, DOI 10.1667/RR1463.1
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Landry Y, 2010, J CELL MOL MED, V14, P1594, DOI 10.1111/j.1582-4934.2009.00887.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mehrara BJ, 2010, FASEB J, V24, P4877, DOI 10.1096/fj.10-155762
   Mertens AC, 2008, J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707
   Mostoufi-Moab S, 2012, J BONE MINER RES, V27, P760, DOI 10.1002/jbmr.1499
   Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Saeed H, 2011, J BONE MINER RES, V26, P1494, DOI 10.1002/jbmr.349
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6
   Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106
   Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x
   Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178
NR 38
TC 21
Z9 23
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2013
VL 8
IS 8
AR e73206
DI 10.1371/journal.pone.0073206
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 209DO
UT WOS:000323734600060
PM 24009740
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Burton, DGA
   Giribaldi, MG
   Munoz, A
   Halvorsen, K
   Patel, A
   Jorda, M
   Perez-Stable, C
   Rai, P
AF Burton, Dominick G. A.
   Giribaldi, Maria G.
   Munoz, Anisleidys
   Halvorsen, Katherine
   Patel, Asmita
   Jorda, Merce
   Perez-Stable, Carlos
   Rai, Priyamvada
TI Androgen Deprivation-Induced Senescence Promotes Outgrowth of
   Androgen-Refractory Prostate Cancer Cells
SO PLOS ONE
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; DNA-DAMAGE; HUMAN
   FIBROBLASTS; IN-VIVO; PREMATURE SENESCENCE; STROMAL FIBROBLASTS;
   RECEPTOR ACTIVATION; INDEPENDENT GROWTH; INDUCED APOPTOSIS
AB Androgen deprivation (AD) is an effective method for initially suppressing prostate cancer (PC) progression. However, androgen-refractory PC cells inevitably emerge from the androgen-responsive tumor, leading to incurable disease. Recent studies have shown AD induces cellular senescence, a phenomenon that is cell-autonomously tumor-suppressive but which confers tumor-promoting adaptations that can facilitate the advent of senescence-resistant malignant cell populations. Because androgen-refractory PC cells emerge clonally from the originally androgen-responsive tumor, we sought to investigate whether AD-induced senescence (ADIS) affects acquisition of androgen-refractory behavior in androgen-responsive LNCaP and LAPC4 prostate cancer cells. We find that repeated exposure of these androgen-responsive cells to senescence-inducing stimuli via cyclic AD leads to the rapid emergence of ADIS-resistant, androgen-refractory cells from the bulk senescent cell population. Our results show that the ADIS phenotype is associated with tumor-promoting traits, notably chemoresistance and enhanced pro-survival mechanisms such as inhibition of p53-mediated cell death, which encourage persistence of the senescent cells. We further find that pharmacologic enforcement of p53/Bax activation via Nutlin-3 prior to establishment of ADIS is required to overcome the associated pro-survival response and preferentially trigger pervasive cell death instead of senescence during AD. Thus our study demonstrates that ADIS promotes outgrowth of androgen-refractory PC cells and is consequently a suboptimal tumor-suppressor response to AD.
C1 [Burton, Dominick G. A.; Giribaldi, Maria G.; Munoz, Anisleidys; Halvorsen, Katherine; Patel, Asmita; Perez-Stable, Carlos; Rai, Priyamvada] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.
   [Giribaldi, Maria G.; Munoz, Anisleidys] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.
   [Jorda, Merce] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Perez-Stable, Carlos] Bruce W Carter Vet Affairs Med Ctr, Miami, FL USA.
   [Perez-Stable, Carlos; Rai, Priyamvada] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.
RP Rai, P (reprint author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.
EM prai@med.miami.edu
RI Burton, Dominick/C-5282-2013
OI Burton, Dominick/0000-0003-3631-6448; Rai,
   Priyamvada/0000-0001-7822-7553
FU University of Miami/Stanley Glaser Foundation award; Sylvester
   Comprehensive Cancer Center Summer Undergraduate Research Award;
   University of Miami/Sylvester Comprehensive Cancer Center Pap Corps
   Developmental Cancer Research Grant; Florida Biomed Bankhead Coley New
   Investigator Award
FX This work was funded by a Florida Biomed Bankhead Coley New Investigator
   Award, a University of Miami/Sylvester Comprehensive Cancer Center Pap
   Corps Developmental Cancer Research Grant and a University of
   Miami/Stanley Glaser Foundation award (to PR). MGG was partially
   supported by a Sylvester Comprehensive Cancer Center Summer
   Undergraduate Research Award. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780
   Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869
   APRIKIAN AG, 1994, J UROLOGY, V151, P1276, DOI 10.1016/S0022-5347(17)35231-X
   Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955
   Burchardt M, 2001, PROSTATE, V48, P225, DOI 10.1002/pros.1101
   Campisi J, 2010, CURR OPIN GENE DEV, V21, P107
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen JH, 2005, DNA REPAIR, V4, P1140, DOI 10.1016/j/j.dnarep.2005.06.003
   Cheng L, 1999, CANCER, V85, P1293, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1293::AID-CNCR11>3.0.CO;2-O
   Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Craft N, 1999, CANCER RES, V59, P5030
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Dean JP, 2008, BRIT J CANCER, V98, P245, DOI 10.1038/sj.bjc.6604087
   Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200
   Di Como CJ, 1999, MOL CELL BIOL, V19, P1438
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304
   Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2
   Ewald JA, 2012, PROSTATE
   Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009
   Gingrich JR, 1996, CANCER RES, V56, P4096
   Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238
   Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013
   Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813
   Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735
   Hampel B, 2004, EXP GERONTOL, V39, P1713, DOI 10.1016/j.exger.2004.05.010
   Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Hsieh TC, 1997, INT J ONCOL, V10, P1109
   Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10
   Jenster G, 1999, SEMIN ONCOL, V26, P407
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305
   Khandrika L, 2009, ONCOGENE, V28, P1248, DOI 10.1038/onc.2008.476
   Kishi H, 2004, J UROLOGY, V171, P1855, DOI 10.1097/01.ju.0000120317.88372.03
   Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213
   Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941
   Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Linja MJ, 2001, CANCER RES, V61, P3550
   Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452
   Lu S, 1997, CANCER RES, V57, P4511
   Lu S, 1999, ENDOCRINOLOGY, V140, P5054, DOI 10.1210/en.140.11.5054
   Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007
   Mirochnik Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031052
   Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249
   Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107
   Mu Z, 2008, PROSTATE, V68, P599, DOI 10.1002/pros.20731
   Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795
   NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286
   Pazolli E, 2009, CANCER RES, V69, P1230, DOI 10.1158/0008-5472.CAN-08-2970
   Peacock SO, 2012, MOL ENDOCRINOL, V26, P1967, DOI 10.1210/me.2012-1165
   Pernicova Z, 2011, NEOPLASIA, V13, P526, DOI 10.1593/neo.11182
   Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067
   Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106
   Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366
   Rieber M, 2009, INT J CANCER, V125, P1604, DOI 10.1002/ijc.24512
   Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Seluanov A, 2001, MOL CELL BIOL, V21, P1552, DOI 10.1128/MCB.21.5.1552-1564.2001
   Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7
   Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239
   Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102
   Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769
   Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803
   Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003
   Tokar EJ, 2005, DIFFERENTIATION, V73, P463, DOI 10.1111/j.1432-0436.2005.00047.x
   Toussaint O, 2002, INT J BIOCHEM CELL B, V34, P1415, DOI 10.1016/S1357-2725(02)00034-1
   Tovar C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-49
   Tsai KKC, 2009, RADIAT RES, V172, P306, DOI 10.1667/RR1764.1
   Tso CL, 2000, CANCER J, V6, P220
   van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   WANG E, 1995, CANCER RES, V55, P2284
   Wen Y, 2000, CANCER RES, V60, P6841
   Wilson C, 2008, MOL CANCER THER, V7, P2649, DOI 10.1158/1535-7163.MCT-08-0148
   Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103
   Yu EY, 2010, J CLIN ONCOL, V28, P2668, DOI 10.1200/JCO.2009.25.1330
   Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882
   Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490
NR 89
TC 13
Z9 14
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 28
PY 2013
VL 8
IS 6
AR e68003
DI 10.1371/journal.pone.0068003
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 174IH
UT WOS:000321148400152
PM 23840802
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Malaquin, N
   Vercamer, C
   Bouali, F
   Martien, S
   Deruy, E
   Wernert, N
   Chwastyniak, M
   Pinet, F
   Abbadie, C
   Pourtier, A
AF Malaquin, Nicolas
   Vercamer, Chantal
   Bouali, Fatima
   Martien, Sebastien
   Deruy, Emeric
   Wernert, Nicolas
   Chwastyniak, Maggy
   Pinet, Florence
   Abbadie, Corinne
   Pourtier, Albin
TI Senescent Fibroblasts Enhance Early Skin Carcinogenic Events via a
   Paracrine MMP-PAR-1 Axis
SO PLOS ONE
LA English
DT Article
ID EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCYTE GROWTH-FACTOR; THROMBIN
   RECEPTOR PAR-1; MET TYROSINE KINASE; ACTIVATED RECEPTOR-1; MATRIX
   METALLOPROTEINASES; KERATINOCYTE MIGRATION; SECRETORY PHENOTYPE;
   CELL-PROLIFERATION; CANCER
AB The incidence of carcinoma increases greatly with aging, but the cellular and molecular mechanisms underlying this correlation are only partly known. It is established that senescent fibroblasts promote the malignant progression of already-transformed cells through secretion of inflammatory mediators. We investigated here whether the senescent fibroblast secretome might have an impact on the very first stages of carcinogenesis. We chose the cultured normal primary human epidermal keratinocyte model, because after these cells reach the senescence plateau, cells with transformed and tumorigenic properties systematically and spontaneously emerge from the plateau. In the presence of medium conditioned by autologous senescent dermal fibroblasts, a higher frequency of post-senescence emergence was observed and the post-senescence emergent cells showed enhanced migratory properties and a more marked epithelial-mesenchymal transition. Using pharmacological inhibitors, siRNAs, and blocking antibodies, we demonstrated that the MMP-1 and MMP-2 matrix metalloproteinases, known to participate in late stages of cancer invasion and metastasis, are responsible for this enhancement of early migratory capacity. We present evidence that MMPs act by activating the protease-activated receptor 1 (PAR-1), whose expression is specifically increased in post-senescence emergent keratinocytes. The physiopathological relevance of these results was tested by analyzing MMP activity and PAR-1 expression in skin sections. Both were higher in skin sections from aged subjects than in ones from young subjects. Altogether, our results suggest that during aging, the dermal and epidermal skin compartments might be activated coordinately for initiation of skin carcinoma, via a paracrine axis in which MMPs secreted by senescent fibroblasts promote very early epithelial-mesenchymal transition of keratinocytes undergoing transformation and oversynthesizing the MMP-activatable receptor PAR-1.
C1 [Malaquin, Nicolas; Vercamer, Chantal; Bouali, Fatima; Martien, Sebastien; Deruy, Emeric; Abbadie, Corinne; Pourtier, Albin] Inst Biol Lille, CNRS, Unite Mixte Rech UMR 8161, Lille, France.
   [Malaquin, Nicolas; Vercamer, Chantal; Bouali, Fatima; Martien, Sebastien; Deruy, Emeric; Abbadie, Corinne; Pourtier, Albin] Univ Lille1 Sci & Technol, UMR 8161, Villeneuve Dascq, France.
   [Malaquin, Nicolas; Vercamer, Chantal; Bouali, Fatima; Martien, Sebastien; Deruy, Emeric; Abbadie, Corinne; Pourtier, Albin] Univ Lille 2, UMR 8161, Lille, France.
   [Malaquin, Nicolas; Vercamer, Chantal; Bouali, Fatima; Martien, Sebastien; Deruy, Emeric; Chwastyniak, Maggy; Pinet, Florence; Abbadie, Corinne; Pourtier, Albin] Inst Pasteur, Lille, France.
   [Chwastyniak, Maggy; Pinet, Florence] INSERM, Unite Mixte Rech UMR 744, F-59045 Lille, France.
   [Wernert, Nicolas] Univ Bonn, Inst Pathol, Dept Mol Pathol, Bonn, Germany.
RP Pourtier, A (reprint author), Inst Biol Lille, CNRS, Unite Mixte Rech UMR 8161, Lille, France.
EM albin.pourtier@ibl.fr
RI ABBADIE, Corinne/F-4949-2018; Pinet, Florence/F-2892-2013
OI ABBADIE, Corinne/0000-0002-8174-2393; Pinet,
   Florence/0000-0002-5471-1487
FU CNRS; Universite de Lille1; Ligue Contre le Cancer (Comite du
   Pas-de-Calais); Association pour la Recherche sur le Cancer; Pasteur
   Institute of Lille; Region Nord-Pas-de-Calais/CNRS; Ligue Nationale
   contre le Cancer; French Research Ministry and Fondation pour la
   Recherche Medicale; Pasteur Institute of Lille/Region Nord-Pas-de-Calais
FX This work was supported by CNRS, Universite de Lille1, Ligue Contre le
   Cancer (Comite du Pas-de-Calais), Association pour la Recherche sur le
   Cancer, and Pasteur Institute of Lille. N. M. had a Ph.D. fellowship
   from Region Nord-Pas-de-Calais/CNRS and Ligue Nationale contre le
   Cancer. S. M. had a Ph.D. fellowship from French Research Ministry and
   Fondation pour la Recherche Medicale. E. D. had a fellowship from
   Pasteur Institute of Lille/Region Nord-Pas-de-Calais. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Algermissen B, 2000, ARCH DERMATOL RES, V292, P488, DOI 10.1007/s004030000168
   Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005
   Arciniegas E, 2004, DNA CELL BIOL, V23, P815, DOI 10.1089/1044549042729603
   Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Bergmann S, 2006, ONCOL REP, V15, P889
   Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005
   Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272
   Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018
   Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004
   BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carragher LAS, 2010, EMBO MOL MED, V2, P458, DOI 10.1002/emmm.201000099
   Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6
   CHEN JD, 1995, J INVEST DERMATOL, V104, P729, DOI 10.1111/1523-1747.ep12606970
   Choi J, 2000, UROLOGY, V56, P160, DOI 10.1016/S0090-4295(00)00538-0
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Deruy E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012712
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909
   Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002
   Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156
   Fujimoto D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-443
   Furlan A, 2008, J CELL PHYSIOL, V215, P782, DOI 10.1002/jcp.21360
   Gallucci RM, 2004, J INVEST DERMATOL, V122, P764, DOI 10.1111/j.0022-202X.2004.22323.x
   Gao L, 2010, EXP CELL RES, V316, P376, DOI 10.1016/j.yexcr.2009.10.022
   Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6
   Gosselin K, 2009, CANCER RES, V69, P7917, DOI 10.1158/0008-5472.CAN-08-2510
   Gosselin K, 2009, AM J PATHOL, V174, P423, DOI 10.2353/ajpath.2009.080332
   GYULAI R, 1994, CLIN EXP DERMATOL, V19, P309, DOI 10.1111/j.1365-2230.1994.tb01201.x
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HOXIE JA, 1993, J BIOL CHEM, V268, P13756
   Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003
   Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2
   Karagas M., 2006, CANC EPIDEMIOLOGY PR, P1230
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Laberge RM, 2012, CANCER MICROENVIRON, V5, P39, DOI 10.1007/s12307-011-0069-4
   Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861
   Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281
   MATSUMOTO K, 1991, EXP CELL RES, V196, P114, DOI 10.1016/0014-4827(91)90462-4
   McCawley LJ, 1998, J CELL PHYSIOL, V176, P255, DOI 10.1002/(SICI)1097-4652(199808)176:2<255::AID-JCP4>3.0.CO;2-N
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Mine S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004066
   Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811
   Orlichenko LS, 2008, CLIN EXP METASTAS, V25, P593, DOI 10.1007/s10585-008-9143-9
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Porto IM, 2009, J HISTOCHEM CYTOCHEM, V57, P615, DOI 10.1369/jhc.2009.952127
   Radisky DC, 2006, CURR OPIN GENET DEV, V16, P45, DOI 10.1016/j.gde.2005.12.011
   Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025
   Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579
   Sabe H, 2011, J BIOCHEM, V149, P633, DOI 10.1093/jb/mvr044
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223
   Stella MC, 1999, INT J BIOCHEM CELL B, V31, P1357, DOI 10.1016/S1357-2725(99)00089-8
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822
   Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371
   Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216
   Tulasne D, 1999, MOL BIOL CELL, V10, P551, DOI 10.1091/mbc.10.3.551
   Villares GJ, 2011, ONCOTARGET, V2, P8
   Wheless L, 2010, CANCER EPIDEM BIOMAR, V19, P1686, DOI 10.1158/1055-9965.EPI-10-0243
   Yamaguchi J, 2009, LAB INVEST, V89, P1018, DOI 10.1038/labinvest.2009.65
   Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103
   Ruiz-Loredo AY, 2011, J CELL PHYSIOL, V226, P414, DOI 10.1002/jcp.22347
   Zdanov S, 2007, EXP CELL RES, V313, P3046, DOI 10.1016/j.yexcr.2007.04.033
   Zigler M, 2011, CANCER RES, V71, P6561, DOI 10.1158/0008-5472.CAN-11-1432
NR 76
TC 37
Z9 39
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 10
PY 2013
VL 8
IS 5
AR e63607
DI 10.1371/journal.pone.0063607
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 143FO
UT WOS:000318852400047
PM 23675494
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Bellei, B
   Pitisci, A
   Ottaviani, M
   Ludovici, M
   Cota, C
   Luzi, F
   Dell'Anna, ML
   Picardo, M
AF Bellei, Barbara
   Pitisci, Angela
   Ottaviani, Monica
   Ludovici, Matteo
   Cota, Carlo
   Luzi, Fabiola
   Dell'Anna, Maria Lucia
   Picardo, Mauro
TI Vitiligo: A Possible Model of Degenerative Diseases
SO PLOS ONE
LA English
DT Article
ID ELEMENT-BINDING PROTEIN; BLOOD MONONUCLEAR-CELLS; HYDROGEN-PEROXIDE
   H2O2; ALZHEIMERS-DISEASE; GENERALIZED VITILIGO; LESIONAL SKIN;
   PARKINSONS-DISEASE; OXIDATIVE STRESS; CYCLE ARREST; TNF-ALPHA
AB Vitiligo is characterized by the progressive disappearance of pigment cells from skin and hair follicle. Several in vitro and in vivo studies show evidence of an altered redox status, suggesting that loss of cellular redox equilibrium might be the pathogenic mechanism in vitiligo. However, despite the numerous data supporting a pathogenic role of oxidative stress, there is still no consensus explanation underlying the oxidative stress-driven disappear of melanocytes from the epidermis. In this study, in vitro characterization of melanocytes cultures from non-lesional vitiligo skin revealed at the cellular level aberrant function of signal transduction pathways common with neurodegenerative diseases including modification of lipid metabolism, hyperactivation of mitogen-activated protein kinase (MAPK) and cAMP response element-binding protein (CREB), constitutive p53-dependent stress signal transduction cascades, and enhanced sensibility to pro-apoptotic stimuli. Notably, these long-term effects of subcytotoxic oxidative stress are also biomarkers of pre-senescent cellular phenotype. Consistent with this, vitiligo cells showed a significant increase in p16 that did not correlate with the chronological age of the donor. Moreover, vitiligo melanocytes produced many biologically active proteins among the senescence-associated secretory phenotype (SAPS), such as interleukin-6 (IL-6), matrix metallo proteinase-3 (MMP3), cyclooxygenase-2 (Cox-2), insulin-like growth factor-binding protein-3 and 7 (IGFBP3, IGFBP7). Together, these data argue for a complicated pathophysiologic puzzle underlying melanocytes degeneration resembling, from the biological point of view, neurodegenerative diseases. Our results suggest new possible targets for intervention that in combination with current therapies could correct melanocytes intrinsic defects.
C1 [Bellei, Barbara; Pitisci, Angela; Ottaviani, Monica; Ludovici, Matteo; Dell'Anna, Maria Lucia; Picardo, Mauro] Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy.
   [Cota, Carlo] Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Dermatopathol Unit, Rome, Italy.
   [Luzi, Fabiola] Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Rome, Italy.
RP Bellei, B (reprint author), Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy.
EM bellei@ifo.it
RI Ludovici, Matteo/H-2159-2016; Bellei, Barbara/K-5288-2016; Ottaviani,
   Monica/J-3183-2016; Picardo, Mauro/A-6978-2011
OI Ludovici, Matteo/0000-0001-7517-2315; Bellei,
   Barbara/0000-0002-3883-5500; Ottaviani, Monica/0000-0002-6613-2570;
   Picardo, Mauro/0000-0003-4899-6639; Cota, Carlo/0000-0001-6335-8649
FU Ministry of Health, Italy
FX The study was partially supported by Ministry of Health, Italy. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. No additional
   funding received for this study.
CR Akterin S, 2006, CELL DEATH DIFFER, V13, P1454, DOI 10.1038/sj.cdd.4401818
   Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200
   Birol A, 2006, INT J DERMATOL, V45, P992, DOI 10.1111/j.1365-4632.2006.02744.x
   Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750
   Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281
   Blagosklonny MV, 2009, CELL CYCLE, V8, P1883, DOI 10.4161/cc.8.12.8815
   Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806
   Boissy RE, 2004, PIGM CELL RES, V17, P208, DOI 10.1111/j.1600-0749.2004.00130.x
   Bondanza S, 2007, PIGM CELL RES, V20, P288, DOI 10.1111/j.1600-0749.2007.00385.x
   CHEN J, 2006, AM J PHYSIOL-HEART C, V290, P1729, DOI DOI 10.1152/AJPHEART.01103.2005
   Condemine W, 2007, J CELL SCI, V120, P3219, DOI 10.1242/jcs.007492
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dell'Anna ML, 2007, J INVEST DERMATOL, V127, P1226, DOI 10.1038/sj.jid.5700700
   Dell'Anna ML, 2012, EXP DERMATOL, V21, P490, DOI 10.1111/j.1600-0625.2012.01506.x
   Dell'Anna ML, 2003, PIGM CELL RES, V16, P553, DOI 10.1034/j.1600-0749.2003.00087.x
   Dumont P, 2000, J ANAT, V197, P529, DOI 10.1046/j.1469-7580.2000.19740529.x
   Eising R, 2003, PLANT PHYSIOL, V97, P1422
   Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089
   Feily A, 2011, ARCH DERMATOL RES, V303, P623, DOI 10.1007/s00403-011-1165-5
   Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x
   Gatza C, 2007, CELL CYCLE, V6, P52, DOI 10.4161/cc.6.1.3667
   Gauthier Y, 2003, PIGM CELL RES, V16, P322, DOI 10.1034/j.1600-0749.2003.00070.x
   Gauthier Y, 2003, BRIT J DERMATOL, V148, P95, DOI 10.1046/j.1365-2133.2003.05024.x
   Giovannelli L, 2004, MUTAT RES-FUND MOL M, V556, P101, DOI 10.1016/j.mrfmmm.2004.07.005
   Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100
   Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765
   JIMBOW K, 1975, J CELL BIOL, V66, P663, DOI 10.1083/jcb.66.3.663
   Kauser S, 2011, J INVEST DERMATOL, V131, P979, DOI 10.1038/jid.2010.397
   Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x
   Kostyuk VA, 2010, ANTIOXID REDOX SIGN, V13, P607, DOI 10.1089/ars.2009.2976
   Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200
   Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607
   Le Poole I. Caroline, 2008, V10, P227, DOI 10.1159/000131485
   Lee HC, 2001, BIOGERONTOLOGY, V2, P231, DOI 10.1023/A:1013270512172
   Malik B, 2008, CELL CYCLE, V7, P637, DOI 10.4161/cc.7.5.5427
   Maresca V, 1997, J INVEST DERMATOL, V109, P310, DOI 10.1111/1523-1747.ep12335801
   MEDRANO EE, 1990, J INVEST DERMATOL, V95, P441
   Mendonsa G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004655
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108
   Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010
   Nakamura M, 2003, EXP CELL RES, V290, P381, DOI 10.1016/S0014-4827(03)00343-4
   Natarajan VT, 2010, J INVEST DERMATOL, V130, P2781, DOI 10.1038/jid.2010.201
   Ohno-Iwashita Y, 2010, GERIATR GERONTOL S1, V10, P41
   Pani A, 2009, J ALZHEIMERS DIS, V18, P829, DOI 10.3233/JAD-2009-1193
   Pani A, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-66
   Park HY, 2011, J INVEST DERMATOL, V132, P835
   Ruzankina Y, 2008, MECH AGEING DEV, V129, P1313
   Salem MMAEL, 2009, FASEB J, V23, P3790, DOI 10.1096/fj.09-132621
   Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]
   Schallreuter KU, 2008, J INVEST DERMATOL, V128, P808, DOI 10.1038/sj.jid.5701100
   Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189
   Schallreuter KU, 2003, EXP DERMATOL, V12, P268, DOI 10.1034/j.1600-0625.2003.00084.x
   Schallreuter KU, 2002, DERMATOLOGY, V204, P194, DOI 10.1159/000057881
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x
   Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501
   Taieb A, 2011, PIGMENT CELL MEL RES, V25, P9
   Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388
   Tobin DJ, 2000, J PATHOL, V191, P407
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Yaar M, 2001, CLIN EXP DERMATOL, V26, P583, DOI 10.1046/j.1365-2230.2001.00895.x
   Zdanov S, 2007, EXP CELL RES, V313, P3046, DOI 10.1016/j.yexcr.2007.04.033
NR 63
TC 35
Z9 36
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2013
VL 8
IS 3
AR e59782
DI 10.1371/journal.pone.0059782
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 123VE
UT WOS:000317418500088
PM 23555779
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Andre, T
   Meuleman, N
   Stamatopoulos, B
   De Bruyn, C
   Pieters, K
   Bron, D
   Lagneaux, L
AF Andre, Thibaud
   Meuleman, Nathalie
   Stamatopoulos, Basile
   De Bruyn, Cecile
   Pieters, Karlien
   Bron, Dominique
   Lagneaux, Laurence
TI Evidences of Early Senescence in Multiple Myeloma Bone Marrow
   Mesenchymal Stromal Cells
SO PLOS ONE
LA English
DT Article
ID HEMATOPOIETIC STEM-CELLS; LARGE GENE LISTS; GROWTH-FACTOR; UNDETERMINED
   SIGNIFICANCE; REPLICATIVE SENESCENCE; MONOCLONAL GAMMOPATHY; SECRETORY
   PHENOTYPE; TUMOR SUPPRESSION; CANCER; PROLIFERATION
AB Background: In multiple myeloma, bone marrow mesenchymal stromal cells support myeloma cell growth. Previous studies have suggested that direct and indirect interactions between malignant cells and bone marrow mesenchymal stromal cells result in constitutive abnormalities in the bone marrow mesenchymal stromal cells.
   Design and Methods: The aims of this study were to investigate the constitutive abnormalities in myeloma bone marrow mesenchymal stromal cells and to evaluate the impact of new treatments.
   Results: We demonstrated that myeloma bone marrow mesenchymal stromal cells have an increased expression of senescence-associated beta-galactosidase, increased cell size, reduced proliferation capacity and characteristic expression of senescence-associated secretory profile members. We also observed a reduction in osteoblastogenic capacity and immunomodulatory activity and an increase in hematopoietic support capacity. Finally, we determined that current treatments were able to partially reduce some abnormalities in secreted factors, proliferation and osteoblastogenesis.
   Conclusions: We showed that myeloma bone marrow mesenchymal stromal cells have an early senescent profile with profound alterations in their characteristics. This senescent state most likely participates in disease progression and relapse by altering the tumor microenvironment.
C1 [Andre, Thibaud; Stamatopoulos, Basile; Pieters, Karlien; Lagneaux, Laurence] Univ Libre Bruxelles, Inst Jules Bordet, Lab Clin Cell Therapy, Brussels, Belgium.
   [Meuleman, Nathalie; De Bruyn, Cecile; Bron, Dominique] Inst Jules Bordet, Dept Hematol, B-1000 Brussels, Belgium.
RP Andre, T (reprint author), Univ Libre Bruxelles, Inst Jules Bordet, Lab Clin Cell Therapy, Brussels, Belgium.
EM thibaud.andre@bordet.be
FU FRS-FNRS (Fonds National de la Recherche Scientifique) of Belgium
   [Televie FC79946]
FX This work was supported by a grant provided by the FRS-FNRS (Fonds
   National de la Recherche Scientifique) of Belgium (Grant- Televie
   FC79946). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249
   Arnulf B, 2007, LEUKEMIA, V21, P158, DOI 10.1038/sj.leu.2404466
   Barille-Nion Sophie, 2003, Hematology Am Soc Hematol Educ Program, P248
   Basak GW, 2009, CURR PHARM BIOTECHNO, V10, P335, DOI 10.2174/138920109787847493
   Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307
   Blade J, 2008, LEUKEMIA, V22, P1651, DOI 10.1038/leu.2008.203
   Brody H, 2011, NATURE, V480, pS33, DOI 10.1038/480S33a
   Caers J, 2008, B CANCER, V95, P301, DOI 10.1684/bdc.2008.0600
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Ciavarella S, 2012, BRIT J HAEMATOL, V157, P586, DOI 10.1111/j.1365-2141.2012.09082.x
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621
   Davies FE, 2003, BLOOD, V102, P4504, DOI 10.1182/blood-2003-01-0016
   De Bruyn C, 2011, STEM CELLS DEV, V20, P547, DOI 10.1089/scd.2010.0260
   DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303
   Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193
   Feng YD, 2010, STEM CELLS DEV, V19, P1289, DOI 10.1089/scd.2010.0010
   Fong CY, 2012, J CELL BIOCHEM, V113, P658, DOI 10.1002/jcb.23395
   Garayoa M, 2009, LEUKEMIA, V23, P1515, DOI 10.1038/leu.2009.65
   Garderet L, 2007, LEUKEMIA LYMPHOMA, V48, P2032, DOI 10.1080/10428190701593644
   Giuliani N, 2010, LEUKEMIA, V24, P1368, DOI 10.1038/leu.2010.96
   Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242
   Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220
   Gupta D, 2001, LEUKEMIA, V15, P1950, DOI 10.1038/sj.leu.2402295
   Hassan HT, 1996, ACTA HAEMATOL-BASEL, V95, P257
   Hasskarl J, 2011, LEUKEMIA LYMPHOMA, V52, P247, DOI 10.3109/10428194.2010.529207
   Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188
   Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875
   Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777
   Li BZ, 2007, STEM CELLS DEV, V16, P921, DOI 10.1089/scd.2007.0074
   Li X, 2009, CANCER LETT, V284, P175, DOI 10.1016/j.canlet.2009.04.022
   Lisanti MP, 2011, CELL CYCLE, V10, P2059, DOI 10.4161/cc.10.13.16233
   Mailankody S, 2011, BLOOD, V118, P4086, DOI 10.1182/blood-2011-05-355743
   Martinez-Jaramillo G, 2011, LEUKEMIA RES, V35, P250, DOI 10.1016/j.leukres.2010.06.014
   McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273
   Najar M, 2009, CYTOTHERAPY, V11, P570, DOI 10.1080/14653240903079377
   Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464
   Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442
   Pasqualetti P, 1997, BIOMED PHARMACOTHER, V51, P74, DOI 10.1016/S0753-3322(97)87730-X
   PATCHEN ML, 1991, BLOOD, V77, P472
   Podar K, 2007, BEST PRACT RES CL HA, V20, P597, DOI 10.1016/j.beha.2007.08.002
   Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851
   Raicevic G, 2012, TISSUE ENG PT A, V18, P1410, DOI [10.1089/ten.tea.2011.0434, 10.1089/ten.TEA.2011.0434]
   Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63
   Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391
   Takeda K, 1998, J IMMUNOL, V161, P4652
   Terpos E, 2006, BRIT J HAEMATOL, V135, P688, DOI 10.1111/j.1365-2141.2006.06356.x
   Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847
   Todoerti K, 2010, EXP HEMATOL, V38, P141, DOI 10.1016/j.exphem.2009.11.009
   Tondreau T, 2004, CYTOTHERAPY, V6, P372, DOI 10.1080/14653240410004943
   UCHIYAMA H, 1993, BLOOD, V82, P3712
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   Wallace SR, 2001, CANCER, V91, P1219, DOI 10.1002/1097-0142(20010401)91:7<1219::AID-CNCR1122>3.0.CO;2-1
   Xu XM, 2011, J CANCER RES CLIN, V137, P495, DOI 10.1007/s00432-010-0908-6
   Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x
   Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762
   Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x
   Zdzisinska B, 2008, ARCH IMMUNOL THER EX, V56, P207, DOI 10.1007/s00005-008-0022-5
   Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955
   Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5
   Zlei M, 2007, EXP HEMATOL, V35, P1550, DOI 10.1016/j.exphem.2007.06.016
NR 66
TC 45
Z9 46
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2013
VL 8
IS 3
AR e59756
DI 10.1371/journal.pone.0059756
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 111UM
UT WOS:000316546400063
PM 23555770
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Basu, D
   Reyes-Mugica, M
   Rebbaa, A
AF Basu, Dipanjan
   Reyes-Mugica, Miguel
   Rebbaa, Abdelhadi
TI Role of the Beta Catenin Destruction Complex in Mediating
   Chemotherapy-Induced Senescence-Associated Secretory Phenotype
SO PLOS ONE
LA English
DT Article
ID GLYCOGEN-SYNTHASE KINASE-3; DRUG-RESISTANCE; ANTITUMOR-ACTIVITY;
   CANCER-TREATMENT; TUMOR-CELLS; INHIBITION; WNT; ACTIVATION; EXPRESSION;
   PROLIFERATION
AB Cellular senescence is considered as a tumor suppressive mechanism. Recent evidence indicates however that senescent cells secrete various growth factors and cytokines, some of which may paradoxically promote cancer progression. This phenomenon termed senescence-associated secretory phenotype (SASP) must be inhibited in order for anti-proliferative agents to be effective. The present study was designed to determine whether the beta-catenin destruction complex (BCDC), known to integrate the action of various growth factors and cytokines, would represent a suitable target to inhibit the activity of SASP components. For this, we carried out experiments to determine the effect of drug-induced senescence on secretion of SASP, beta-catenin transactivation, and the relationship between these processes. Moreover, genetic and pharmacological approaches were used to define the implication of BCDC in mediating the effects of SASP components on cell migration and resistance to drugs. The findings indicate that drug-induced senescence was associated with expression of various Wnt ligands in addition to previously known SASP components. Beta catenin transactivation and expression of genes implicated in epithelial-mesenchymal transition (EMT) also increased in response to drug-induced SASP. These effects were prevented by Pyrvinium, a recently described activator of BCDC. Pyrvinium also suppressed the effects of SASP on cell migration and resistance to doxorubicin. Together, these findings provide insights on the potential role of BCDC in mediating the effects of drug-induced SASP on cancer cell invasion and resistance to therapy, and suggest that targeting this pathway may represent an effective approach to enhance the activity of current and prospective anti-cancer therapeutics.
C1 [Rebbaa, Abdelhadi] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.
   UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA.
RP Rebbaa, A (reprint author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.
EM abr25@pitt.edu
RI Basu, Dipanjan/J-8043-2019
OI Basu, Dipanjan/0000-0002-3083-2954
FU University of Pittsburgh
FX This work was supported by startup funds from the University of
   Pittsburgh. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596
   Canino C, 2011, ONCOGENE
   Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599
   Chang BD, 1999, CANCER RES, V59, P3761
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306
   Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356
   Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034
   Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014
   Kendziorra E, 2011, CARCINOGENESIS, V32, P1824, DOI 10.1093/carcin/bgr222
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Laberge RM, 2012, CANCER MICROENVIRON, V5, P39, DOI 10.1007/s12307-011-0069-4
   Laberge RM, 2012, AGING CELL
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Lim JC, 2008, J NEUROCHEM, V106, P1855, DOI 10.1111/j.1471-4159.2008.05537.x
   Lyden D., 2011, CANC METASTASIS BIOL
   Mirkin BL, 2005, ONCOGENE, V24, P4965, DOI 10.1038/sj.onc.1208671
   Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386
   Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366
   Rebbaa A, 2001, MOL MED, V7, P393, DOI 10.1007/BF03402185
   Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Roninson IB, 2003, CANCER RES, V63, P2705
   Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108
   Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005
   Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518
   Tenbaum S. P., 2012, NAT MED
   Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884
   Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453
   Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337
   Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9
   Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111
   Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951
   Zheng X, 2004, CANCER RES, V64, P1773, DOI 10.1158/0008-5472.CAN-03-0820
NR 40
TC 15
Z9 15
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 18
PY 2012
VL 7
IS 12
AR e52188
DI 10.1371/journal.pone.0052188
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 056JC
UT WOS:000312483300068
PM 23272224
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Gu, LB
   Kitamura, M
AF Gu, Liubao
   Kitamura, Masanori
TI Sensitive Detection and Monitoring of Senescence-Associated Secretory
   Phenotype by SASP-RAP Assay
SO PLOS ONE
LA English
DT Article
ID CELLULAR SENESCENCE; GENE-EXPRESSION; ALKALINE-PHOSPHATASE; ER STRESS;
   IN-VIVO; CANCER; CELLS; TRANSCRIPTION; FIBROBLASTS; INHIBITOR
AB Senescence-associated secretory phenotype (SASP) is characterized by abundant secretion of various proteins in senescent cells and implicated in tumor progression and inflammatory responses. However, the profile of secreted proteins in SASP is different from cell type to cell type, and currently, universal markers for SASP have not been reported. In the present investigation, we show that SASP-responsive alkaline phosphatase (SASP-RAP) serves as a sensitive, general and convenient marker for SASP. Etoposide-treated cells exhibited a senescent phenotype characterized by senile morphology, positive staining for senescence-associated beta-galactosidase, growth arrest and induction of p53 and p21(WAF1/CIP1). In SASP-RAP-transfected cells, exposure to etoposide increased secretion of SASP-RAP time-dependently. The kinetics of secretion was closely correlated with that of activation of the p21(WAF1/CIP1) promoter and the p16(INK4a) promoter. The enhanced secretion of SASP-RAP by senescence was also observed in cells treated with other senescence inducers such as trichostatin A, doxorubicin and 4-phenylbutylic acid. The induction of SASP-RAP by senescence was similarly observed in natural replicative senescence. To confirm selectivity of the SASP-RAP response, cells were treated with senescence-related and unrelated stimuli (IL-1 beta, LPS, TNF-alpha and TGF-beta), and induction of senescence markers and activity of SASP-RAP were evaluated in parallel. Unlike etoposide, senescence-unrelated stimuli did not induce p53 and p21(WAF1/CIP1), and it was correlated with lack of induction of SASP-RAP. In contrast, senescence-unrelated stimuli up-regulated conventional indicators for SASP, e.g., MMP-3, IL-6 and TIMP, without induction of senescence. SASP-RAP thus serves as a selective, convenient and general marker for detection and monitoring of SASP during cellular senescence.
C1 [Gu, Liubao; Kitamura, Masanori] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.
   [Gu, Liubao] Jiangsu Prov Inst Geriatr, Diabet Care & Res Ctr, Nanjing, Jiangsu, Peoples R China.
RP Kitamura, M (reprint author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.
EM masanori@yamanashi.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [20390235]
FX This work was supported by Grant-in-Aids for Scientific Research from
   the Ministry of Education, Culture, Sports, Science and Technology,
   Japan (20390235) to M. Kitamura (http://www.mext.go.jp/english/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3
   Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   CULLEN BR, 1992, METHOD ENZYMOL, V216, P362
   Demarchi F, 2010, CELL CYCLE, V9, P755, DOI 10.4161/cc.9.4.10637
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Hiramatsu N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl515
   HUPPI K, 1994, ONCOGENE, V9, P3017
   Johno H, 2010, APPL BIOCHEM BIOTECH, V162, P1529, DOI 10.1007/s12010-010-8934-z
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kasai A, 2005, ANAL BIOCHEM, V337, P84, DOI 10.1016/j.ab.2004.10.004
   Kasai A, 2004, ANAL BIOCHEM, V335, P73, DOI 10.1016/j.ab.2004.08.017
   Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98
   Kitamura M, 2011, CELL DEATH DIFFER, V18, P1876, DOI 10.1038/cdd.2011.63
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/B978-0-12-380866-0.60002-2, 10.1016/S0065-2660(10)70002-X]
   Kurihara Y, 2002, BIOL PHARM BULL, V25, P1272, DOI 10.1248/bpb.25.1272
   Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265
   MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x
   Matsumoto A, 2000, BIOORG MED CHEM LETT, V10, P865
   Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10
   Narita M, 2007, BRIT J CANCER, V96, P686, DOI 10.1038/sj.bjc.6603636
   Ogryzko VV, 1996, MOL CELL BIOL, V16, P5210
   Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104
   Qiu Z, 2009, IMMUNOBIOLOGY, V214, P835, DOI 10.1016/j.imbio.2009.06.007
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Shin DM, 2011, GERONTOLOGY, V57, P76, DOI 10.1159/000281882
   Tominaga K, 1997, MOL IMMUNOL, V34, P1147, DOI 10.1016/S0161-5890(97)00145-4
   VANSNICK J, 1988, EUR J IMMUNOL, V18, P193
   WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925
NR 40
TC 6
Z9 6
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 18
PY 2012
VL 7
IS 12
AR e52305
DI 10.1371/journal.pone.0052305
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 056JC
UT WOS:000312483300078
PM 23272236
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Gharaee-Kermani, M
   Kasina, S
   Moore, BB
   Thomas, D
   Mehra, R
   Macoska, JA
AF Gharaee-Kermani, Mehrnaz
   Kasina, Sathish
   Moore, Bethany B.
   Thomas, Dafydd
   Mehra, Rohit
   Macoska, Jill A.
TI CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic
   Fibrosis
SO PLOS ONE
LA English
DT Article
ID URINARY-TRACT SYMPTOMS; REACTIVE STROMA; GROWTH-FACTOR; TGF-BETA;
   TRANSFORMING GROWTH-FACTOR-BETA-1; CELLULAR PROLIFERATION;
   PULMONARY-FIBROSIS; MOLECULAR TARGETS; EPITHELIAL-CELLS; HUMAN BLADDER
AB Recent studies from our group suggest that extracellular matrix (ECM) deposition and fibrosis characterize the peri-urethral prostate tissues of some men suffering from Lower Urinary Tract Symptoms (LUTS) and that fibrosis may be a contributing factor to the etiology of LUTS. Fibrosis can generally be regarded as an errant wound-healing process in response to chronic inflammation, and several studies have shown that the aging prostate tissue microenvironment is rich with inflammatory cells and proteins. However, it is unclear whether these same inflammatory proteins, particularly CXC-type chemokines, can mediate myofibroblast phenoconversion and the ECM deposition necessary for the development of prostatic tissue fibrosis. To examine this, immortalized and primary prostate stromal fibroblasts treated with TGF-beta 1, CXCL5, CXCL8, or CXCL12 were evaluated morphologically by microscopy, by immunofluorescence and qRT-PCR for alpha SMA, collagen 1, vimentin, calponin, and tenascin protein and transcript expression, and by gel contraction assays for functional myofibroblast phenoconversion. The results of these studies showed that that immortalized and primary prostate stromal fibroblasts are induced to express collagen 1 and 3 and alpha SMA gene transcripts and proteins and to undergo complete and functional myofibroblast phenoconversion in response to CXC-type chemokines, even in the absence of exogenous TGF-beta 1. Moreover, CXCL12-mediated myofibroblast phenoconversion can be completely abrogated by inhibition of the CXCL12 receptor, CXCR4. These findings suggest that CXC-type chemokines, which comprise inflammatory proteins known to be highly expressed in the aging prostate, can efficiently and completely mediate myofibroblast phenoconversion and may thereby promote fibrotic changes in prostate tissue architecture associated with the development and progression of male lower urinary tract dysfunction.
C1 [Gharaee-Kermani, Mehrnaz; Kasina, Sathish; Macoska, Jill A.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA.
   [Moore, Bethany B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA.
   [Moore, Bethany B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.
   [Thomas, Dafydd; Mehra, Rohit] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA.
RP Macoska, JA (reprint author), Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA.
EM jcoska@umich.edu
OI Moore, Bethany/0000-0003-3051-745X
FU National Institutes of Health (NIH)/National Institute of Diabetes and
   Digestive and Kidney Diseases (NIDDK) [P20DK090770]; Michigan Institute
   for Clinical & Health Research (MICHR) NIH [UL1RR024986]
FX This work was supported by National Institutes of Health (NIH)/National
   Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) award
   P20DK090770 (JAM) and by the Michigan Institute for Clinical & Health
   Research (MICHR) NIH Clinical & Translational Science Award (CTSA)
   UL1RR024986 (MGK). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Arenas MI, 2001, INT J ANDROL, V24, P37, DOI 10.1046/j.1365-2605.2001.00267.x
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Begley L, 2006, GENE CHROMOSOME CANC, V45, P136, DOI 10.1002/gcc.20274
   Begley L, 2005, AGING CELL, V4, P291, DOI 10.1111/j.1474-9726.2005.00173.x
   Begley LA, 2008, CYTOKINE, V43, P194, DOI 10.1016/j.cyto.2008.05.012
   Begley LA, 2007, J BIOL CHEM, V282, P26767, DOI 10.1074/jbc.M700440200
   Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0
   Charlton RG, 1999, BJU INT, V84, P953
   Chkhotua A, 2002, TRANSPL IMMUNOL, V9, P165, DOI 10.1016/S0966-3274(02)00003-5
   Comperat E, 2006, EUR UROL, V50, P1058, DOI 10.1016/j.eururo.2006.01.025
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Cunnington RH, 2011, AM J PHYSIOL-CELL PH, V300, pC176, DOI 10.1152/ajpcell.00050.2010
   DEERING RE, 1994, UROLOGY, V44, P64, DOI 10.1016/S0090-4295(94)80011-1
   Detlefsen S, 2005, VIRCHOWS ARCH, V447, P800, DOI 10.1007/s00428-005-0032-1
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243
   Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072
   EASTHAM JA, 1995, LAB INVEST, V73, P628
   ELBADAWI A, 1993, J UROLOGY, V150, P1657, DOI 10.1016/S0022-5347(17)35867-6
   Francisco IFS, 2004, INT J CANCER, V112, P213, DOI 10.1002/ijc.20388
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952
   Gharaee-Kermani M, 2009, CURR MED CHEM, V16, P1400, DOI 10.2174/092986709787846497
   Goldacre MJ, 2009, BEST PRACT RES CL GA, V23, P793, DOI 10.1016/j.bpg.2009.10.008
   Gosling JA, 1997, EUR UROL, V32, P9
   Gur S, 2008, DRUGS, V68, P209, DOI 10.2165/00003495-200868020-00005
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020
   Hjelmeland LM, 1999, INVEST OPHTH VIS SCI, V40, P1
   Huang XM, 2003, FRONT BIOSCI-LANDMRK, V8, pS740, DOI 10.2741/1093
   International Union of Immunological Societies/World Health Organization Subcommittee on chemokine nomenclature, 2001, J Leukoc Biol, V70, P465
   Jinnin M, 2010, J DERMATOL, V37, P11, DOI 10.1111/j.1346-8138.2009.00738.x
   Kajstura J, 2000, AM J PATHOL, V156, P813, DOI 10.1016/S0002-9440(10)64949-8
   Kasina S, 2012, MOL CELL ENDOCRINOL, V351, P249, DOI 10.1016/j.mce.2011.12.015
   KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492
   Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011
   Kupelian V, 2006, ARCH INTERN MED, V166, P2381, DOI 10.1001/archinte.166.21.2381
   Laborde Eric E, 2009, Rev Urol, V11, pS19
   LEPOR H, 1992, J UROLOGY, V148, P414, DOI 10.1016/S0022-5347(17)36619-3
   Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007
   Macoska JA, 2004, CANCER GENET CYTOGEN, V154, P36, DOI 10.1016/j.cancergencyto.2004.02.013
   McDowell KL, 2010, PROSTATE, V70, P377, DOI 10.1002/pros.21071
   McVary KT, 2007, CLIN THER, V29, P387, DOI 10.1016/j.clinthera.2007.03.016
   Meigs JB, 2001, J CLIN EPIDEMIOL, V54, P935, DOI 10.1016/S0895-4356(01)00351-1
   MORI H, 1990, PROSTATE, V16, P71, DOI 10.1002/pros.2990160108
   Nickel JC, 1999, BJU INT, V84, P976
   Nishimura F, 1997, Oral Dis, V3, P162
   Novo E, 2009, INT J BIOCHEM CELL B, V41, P2089, DOI 10.1016/j.biocel.2009.03.010
   Okada H, 1998, AM J PHYSIOL-RENAL, V275, pF306
   Parsons JK, 2008, UROLOGY, V72, P318, DOI 10.1016/j.urology.2008.03.057
   Penna G, 2009, J IMMUNOL, V182, P4056, DOI 10.4049/jimmunol.0801875
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004
   Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31
   Rodrigues AA, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.09.033
   Royuela M, 1998, GROWTH FACTORS, V16, P101, DOI 10.3109/08977199809002121
   Schauer IG, 2008, UROLOGY, V72, P205, DOI 10.1016/j.urology.2007.11.083
   Schauer IG, 2009, PROSTATE, V69, P373, DOI 10.1002/pros.20886
   Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009
   Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568
   Somoza B, 2006, CARDIOVASC RES, V69, P764, DOI 10.1016/j.cardiores.2005.08.021
   Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x
   THEYER G, 1992, LAB INVEST, V66, P96
   Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912
   Tuxhorn JA, 2002, REACTIVE STROMA HUMA
   Van Hoozen BE, 2000, TOXICOLOGY, V147, P1, DOI 10.1016/S0300-483X(00)00142-6
   Verhamme KMC, 2002, EUR UROL, V42, P323, DOI 10.1016/S0302-2838(02)00354-8
   Wang JX, 2011, AM J PHYSIOL-HEART C, V301, pH2073, DOI 10.1152/ajpheart.00157.2011
   Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe
   White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Xie YP, 2012, EXP BIOL MED, V237, P853, DOI 10.1258/ebm.2012.012070
   Zhao H, 2002, BIOCHEM BIOPH RES CO, V292, P482, DOI 10.1006/bbrc.2002.6660
NR 74
TC 31
Z9 31
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 16
PY 2012
VL 7
IS 11
AR e49278
DI 10.1371/journal.pone.0049278
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 048BN
UT WOS:000311885300024
PM 23173053
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Bhat, R
   Crowe, EP
   Bitto, A
   Moh, M
   Katsetos, CD
   Garcia, FU
   Johnson, FB
   Trojanowski, JQ
   Sell, C
   Torres, C
AF Bhat, Rekha
   Crowe, Elizabeth P.
   Bitto, Alessandro
   Moh, Michelle
   Katsetos, Christos D.
   Garcia, Fernando U.
   Johnson, Frederick Bradley
   Trojanowski, John Q.
   Sell, Christian
   Torres, Claudio
TI Astrocyte Senescence as a Component of Alzheimer's Disease
SO PLOS ONE
LA English
DT Article
ID AMYLOID-BETA-PROTEIN; CELLULAR SENESCENCE; SECRETORY PHENOTYPE;
   IN-VITRO; A-BETA; SIGNALING PATHWAY; NATURAL OLIGOMERS; AGING PRIMATES;
   DNA-DAMAGE; HUMAN-SKIN
AB Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n=4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n=6; P=0.02) and 78 to 90 years (n=11; P, 10(-6)). In addition, the frontal cortex of AD patients (n=15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n=25; P=0.02) and fetal controls (n=4; P, 10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (A beta(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.
C1 [Bhat, Rekha; Crowe, Elizabeth P.; Bitto, Alessandro; Moh, Michelle; Katsetos, Christos D.; Garcia, Fernando U.; Sell, Christian; Torres, Claudio] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Johnson, Frederick Bradley; Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Bhat, R (reprint author), Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM claudio.torres@drexelmed.edu
FU National Institutes of Health/National Institute on Aging [AG022443,
   AG022443-S1]; Resident Research Fellowship; Drexel University College of
   Medicine; Medical Student Summer Research Fellowship; Aging Initiative
   Fellowship, Drexel University College of Medicine; Department of
   Pathology, Drexel University College of Medicine
FX The study was supported by National Institutes of Health/National
   Institute on Aging grants AG022443 (CS) and AG022443-S1 (CT); the
   Resident Research Fellowship, Drexel University College of Medicine,
   awarded to RB; the Medical Student Summer Research Fellowship, Drexel
   University College of Medicine, awarded to MM; and the Aging Initiative
   Fellowship, Drexel University College of Medicine, awarded to AB. EPC
   was supported by funds from the Department of Pathology, Drexel
   University College of Medicine. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004
   AHRONHEIM JC, 1983, JAMA-J AM MED ASSOC, V250, P1182, DOI 10.1001/jama.250.9.1182
   Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010
   [Anonymous], 2012, ALZHEIMERS DEMENT, V8, P131
   Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79
   Baker D. J., 2011, NATURE
   Bitto A, 2010, EXP CELL RES, V316, P2961, DOI 10.1016/j.yexcr.2010.06.021
   Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001
   Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF
   Chkhotua AB, 2003, AM J KIDNEY DIS, V41, P1303, DOI 10.1016/S0272-6386(03)00363-9
   Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372
   Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Donnini S, 2010, FASEB J, V24, P2385, DOI 10.1096/fj.09-146456
   Fa M, 2010, J VIS EXP
   Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016
   Golde TE, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt5
   Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031
   Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003
   Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119
   Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Hou LL, 2011, IN VITRO CELL DEV-AN, V47, P573, DOI 10.1007/s11626-011-9439-y
   Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8
   Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x
   Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   KOO EH, 1994, J BIOL CHEM, V269, P17386
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   LI YT, 1994, NEUROBIOL AGING, V15, P1, DOI 10.1016/0197-4580(94)90139-2
   Livney MG, 2011, AM J GERIAT PSYCHIAT, V19, P430, DOI 10.1097/JGP.0b013e3181f7d881
   Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575
   McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010
   Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7
   Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x
   Poling A, 2008, BEHAV BRAIN RES, V193, P230, DOI 10.1016/j.bbr.2008.06.001
   PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945
   Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x
   Rhein V, 2009, CELL MOL NEUROBIOL, V29, P1063, DOI 10.1007/s10571-009-9398-y
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200
   Thies W, 2011, ALZHEIMERS DEMENT, V7, P208, DOI DOI 10.1016/J.JALZ.2011.02.004
   Tresini M, 1998, CANCER RES, V58, P1
   Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC
   Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s
   Wang HY, 2002, NEUROBIOL AGING, V23, P213, DOI 10.1016/S0197-4580(01)00279-2
   WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8
   Zeng GY, 1996, EXP CELL RES, V222, P150, DOI 10.1006/excr.1996.0019
NR 62
TC 141
Z9 142
U1 2
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 12
PY 2012
VL 7
IS 9
AR e45069
DI 10.1371/journal.pone.0045069
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 005GJ
UT WOS:000308738500113
PM 22984612
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Sohn, JJ
   Schetter, AJ
   Yfantis, HG
   Ridnour, LA
   Horikawa, I
   Khan, MA
   Robles, AI
   Hussain, SP
   Goto, A
   Bowman, ED
   Hofseth, LJ
   Bartkova, J
   Bartek, J
   Wogan, GN
   Wink, DA
   Harris, CC
AF Sohn, Jane J.
   Schetter, Aaron J.
   Yfantis, Harris G.
   Ridnour, Lisa A.
   Horikawa, Izumi
   Khan, Mohammed A.
   Robles, Ana I.
   Hussain, S. Perwez
   Goto, Akiteru
   Bowman, Elise D.
   Hofseth, Lorne J.
   Bartkova, Jirina
   Bartek, Jiri
   Wogan, Gerald N.
   Wink, David A.
   Harris, Curtis C.
TI Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage
   Response Pathway and Senescence in Inflammatory Bowel Disease
SO PLOS ONE
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; ULCERATIVE-COLITIS; CELLULAR SENESCENCE;
   COLORECTAL-CANCER; CROHNS-DISEASE; SYNTHASE EXPRESSION; SUSCEPTIBILITY
   LOCI; BREAST-CANCER; TUMOR-GROWTH; IN-VIVO
AB Background: Cellular senescence can be a functional barrier to carcinogenesis. We hypothesized that inflammation modulates carcinogenesis through senescence and DNA damage response (DDR). We examined the association between senescence and DDR with macrophage levels in inflammatory bowel disease (IBD). In vitro experiments tested the ability of macrophages to induce senescence in primary cells. Inflammation modulating microRNAs were identified in senescence colon tissue for further investigation.
   Methodology/Principal Findings: Quantitative immunohistochemistry identified protein expression by colon cell type. Increased cellular senescence (HP1 gamma; P = 0.01) or DDR (gamma H2A.X; P = 0.031, phospho-Chk2, P = 0.014) was associated with high macrophage infiltration in UC. Co-culture with macrophages (ANA-1) induced senescence in .80% of primary cells (fibroblasts MRC5, WI38), illustrating that macrophages induce senescence. Interestingly, macrophage-induced senescence was partly dependent on nitric oxide synthase, and clinically relevant NO center dot levels alone induced senescence. NO center dot induced DDR in vitro, as detected by immunofluorescence. In contrast to UC, we noted in Crohn's disease (CD) that senescence (HP1 gamma; P < 0.001) and DDR (gamma H2A.X; P < 0.05, phospho-Chk2; P < 0.001) were higher, and macrophages were not associated with senescence. We hypothesize that nitric oxide may modulate senescence in CD; epithelial cells of CD had higher levels of NOS2 expression than in UC (P = 0.001). Microarrays and quantitative-PCR identified miR-21 expression associated with macrophage infiltration and NOS2 expression.
   Conclusions: Senescence was observed in IBD with senescence-associated beta-galactosidase and HP1 gamma. Macrophages were associated with senescence and DDR in UC, and in vitro experiments with primary human cells showed that macrophages induce senescence, partly through NO center dot, and that NO center dot can induce DDR associated with senescence. Future experiments will investigate the role of NO center dot and miR-21 in senescence. This is the first study to implicate macrophages and nitrosative stress in a direct effect on senescence and DDR, which is relevant to many diseases of inflammation, cancer, and aging.
C1 [Sohn, Jane J.; Schetter, Aaron J.; Horikawa, Izumi; Khan, Mohammed A.; Robles, Ana I.; Hussain, S. Perwez; Goto, Akiteru; Bowman, Elise D.; Harris, Curtis C.] Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Bethesda, MD USA.
   [Yfantis, Harris G.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.
   [Yfantis, Harris G.] Univ Maryland, Sch Med, Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA.
   [Ridnour, Lisa A.; Wink, David A.] Natl Canc Inst, Radiat Biol Branch, Bethesda, MD USA.
   [Hofseth, Lorne J.] Univ S Carolina, S Carolina Coll Pharm, Dept Pharmaceut & Biomed Sci, Columbia, SC USA.
   [Bartkova, Jirina; Bartek, Jiri] Canc Soc Res Ctr, Copenhagen, Denmark.
   [Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic.
   [Wogan, Gerald N.] MIT, Ctr Environm Hlth Sci, Dept Biol Engn, Cambridge, MA USA.
RP Sohn, JJ (reprint author), Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Bethesda, MD USA.
EM Curtis_Harris@nih.gov
RI Bartek, Jiri/G-5870-2014
FU National Cancer Institute; Danish Cancer Society; Danish National
   Research Foundation; European Commission
FX This research was supported by the Intramural Research Program of the
   National Cancer Institute. Dr. Sohn was supported by the Cancer Research
   Training Award Fellowship from the National Cancer Institute. Dr.
   Bartkova and Dr. Bartek were supported by the Danish Cancer Society, the
   Danish National Research Foundation, and the European Commission
   (projects: Infla-Care, Biomedreg and DDResponse). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647
   Ambs S, 1998, NAT MED, V4, P1371, DOI 10.1038/3957
   Ambs S, 1999, J NATL CANCER I, V91, P86, DOI 10.1093/jnci/91.1.86
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042
   Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016
   Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245
   Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001
   Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x
   Clemons NJ, 2007, GASTROENTEROLOGY, V133, P1198, DOI 10.1053/j.gastro.2007.06.061
   Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492
   DeNicola Gina M, 2009, Eur J Cancer, V45 Suppl 1, P211, DOI 10.1016/S0959-8049(09)70036-X
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802
   Espey MG, 2000, J BIOL CHEM, V275, P11341, DOI 10.1074/jbc.275.15.11341
   Favetta LA, 2004, EXP CELL RES, V299, P36, DOI 10.1016/j.yexcr.2004.05.009
   Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442
   Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717
   Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416
   Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928
   Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104
   Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757
   Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100
   Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173
   Hussain SP, 2000, CANCER RES, V60, P3333
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Jones CJ, 2000, MOL CELL BIOL, V20, P5690, DOI 10.1128/MCB.20.15.5690-5699.2000
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780
   Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063
   LUNDBERG JON, 1994, LANCET, V344, P1673, DOI 10.1016/S0140-6736(94)90460-X
   Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685
   Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7
   Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403
   McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549
   Nair J, 2006, ANTIOXID REDOX SIGN, V8, P1003, DOI 10.1089/ars.2006.8.1003
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989
   Oliveira CJR, 2003, FREE RADICAL BIO MED, V35, P381, DOI 10.1016/S0891-5849(03)00311-3
   Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528
   Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336
   Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106
   Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104
   Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008
   Risques RA, 2011, CANCER RES, V71, P1669, DOI 10.1158/0008-5472.CAN-10-1966
   Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Salk JJ, 2009, P NATL ACAD SCI US
   Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425
   Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240
   Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377
   Stewart BW, 2003, WORLD CANC REPORT, P56
   Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101
   Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020
   Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200
   Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045
   Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
NR 68
TC 33
Z9 34
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 6
PY 2012
VL 7
IS 9
AR e44156
DI 10.1371/journal.pone.0044156
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 001KC
UT WOS:000308458400040
PM 22970173
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Mirochnik, Y
   Veliceasa, D
   Williams, L
   Maxwell, K
   Yemelyanov, A
   Budunova, I
   Volpert, OV
AF Mirochnik, Yelena
   Veliceasa, Dorina
   Williams, Latanya
   Maxwell, Kelly
   Yemelyanov, Alexander
   Budunova, Irina
   Volpert, Olga V.
TI Androgen Receptor Drives Cellular Senescence
SO PLOS ONE
LA English
DT Article
ID PROSTATE-CANCER CELLS; TUMOR-SUPPRESSOR; CYCLE ARREST; MOUSE MODEL;
   STEM-CELLS; IN-VIVO; GROWTH; PROGRESSION; PROLIFERATION; PROTEIN
AB The accepted androgen receptor (AR) role is to promote proliferation and survival of prostate epithelium and thus prostate cancer progression. While growth-inhibitory, tumor-suppressive AR effects have also been documented, the underlying mechanisms are poorly understood. Here, we for the first time link AR anti-cancer action with cell senescence in vitro and in vivo. First, AR-driven senescence was p53-independent. Instead, AR induced p21, which subsequently reduced Delta N isoform of p63. Second, AR activation increased reactive oxygen species (ROS) and thereby suppressed Rb phosphorylation. Both pathways were critical for senescence as was proven by p21 and Rb knock-down and by quenching ROS with N-Acetyl cysteine and p63 silencing also mimicked AR-induced senescence. The two pathways engaged in a cross-talk, likely via PML tumor suppressor, whose localization to senescence-associated chromatin foci was increased by AR activation. All these pathways contributed to growth arrest, which resolved in senescence due to concomitant lack of p53 and high mTOR activity. This is the first demonstration of senescence response caused by a nuclear hormone receptor.
C1 [Mirochnik, Yelena; Veliceasa, Dorina; Williams, Latanya; Maxwell, Kelly; Volpert, Olga V.] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA.
   [Yemelyanov, Alexander; Budunova, Irina] Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA.
RP Mirochnik, Y (reprint author), Northwestern Univ, Dept Urol, Chicago, IL 60611 USA.
EM olgavolp@northwestern.edu
FU PI endowment fund (O'Conor Family endowment); National Institutes of
   Health Cancer Institute [R01 CA118890]; ACS IL Division [160185]
FX This work was supported by the PI endowment fund (O'Conor Family
   endowment, to Olga Volpert), National Institutes of Health Cancer
   Institute grant R01 CA118890 (to PI Budunova) and ACS IL Division, grant
   160185 (to PI Yemelyanov). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Beaudry VG, 2009, CELL STEM CELL, V5, P1, DOI 10.1016/j.stem.2009.06.015
   Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215
   Blagosklonny MV, 2009, CELL CYCLE, V8, P1883, DOI 10.4161/cc.8.12.8815
   Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026
   Calabro V, 2004, MOL CELL BIOL, V24, P8529, DOI 10.1128/MCB.24.19.8529-8540.2004
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974
   Chopra DP, 1996, J CELL PHYSIOL, V169, P269, DOI 10.1002/(SICI)1097-4652(199611)169:2<269::AID-JCP6>3.0.CO;2-M
   Cinar B, 2007, J BIOL CHEM
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Culig Z, 2006, J CELL BIOCHEM, V99, P373, DOI 10.1002/jch.20898
   Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017
   Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407
   Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919
   Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107
   Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606
   Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199
   Eder Iris E, 2005, Future Oncol, V1, P93
   Ferbeyre G, 2002, LEUKEMIA, V16, P1918, DOI 10.1038/sj.leu.2402722
   Gavrielides MV, 2006, CANCER RES, V66, P11792, DOI 10.1158/0008-5472.CAN-06-1139
   Gleave M, 1998, PROSTATE CANCER P D, V1, P289, DOI 10.1038/sj.pcan.4500260
   Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555
   Guo XC, 2007, CELL CYCLE, V6, P305, DOI 10.4161/cc.6.3.3794
   Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029
   Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735
   Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102
   HARPER JW, 1993, CELL, V75, P805
   Hayward SW, 2001, CANCER RES, V61, P8135
   Hess-Wilson JK, 2006, CANCER RES, V66, P11998, DOI 10.1158/0008-5472.CAN-06-2249
   Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Kasper S, 2005, J CELL BIOCHEM, V94, P279, DOI 10.1002/jcb.20339
   Keyes WM, 2006, CELL CYCLE, V5, P260, DOI 10.4161/cc.5.3.2415
   Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305
   Khan MM, 2001, J BIOL CHEM, V276, P43491, DOI 10.1074/jbc.C100532200
   Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941
   Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160
   Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355
   Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584
   Li JP, 2005, ONCOGENE, V24, P5510, DOI 10.1038/sj.onc.1208693
   Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038
   Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228
   Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483
   Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376
   Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Mehraein-Ghomi F, 2008, PROSTATE, V68, P924, DOI 10.1002/pros.20737
   Nelius T, 2007, INT J CANCER, V121, P999, DOI 10.1002/ijc.22802
   O'Mahony OA, 2008, MOL CANCER RES, V6, P1691, DOI 10.1158/1541-7786.MCR-08-0273
   Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007
   Rambeaud JJ, 1999, EUR UROL, V35, P32, DOI 10.1159/000052305
   Reiner T, 2007, MOL CANCER RES, V5, P1171, DOI 10.1158/1541-7786.MCR-07-0024
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Signoretti S, 2006, CELL CYCLE, V5, P138, DOI 10.4161/cc.5.2.2340
   Stewart JR, 2005, MOL CANCER THER, V4, P726, DOI 10.1158/1535-7163.MCT-05-0013
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Tokar EJ, 2005, DIFFERENTIATION, V73, P463, DOI 10.1111/j.1432-0436.2005.00047.x
   van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290
   Vander Griend DJ, 2007, CELL CYCLE, V6, P647, DOI 10.4161/cc.6.6.4028
   Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552
   Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697
   Wang XT, 2004, CANCER RES, V64, P1377, DOI 10.1158/0008-5472.CAN-03-2428
   Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104
   Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472
NR 66
TC 25
Z9 25
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 5
PY 2012
VL 7
IS 3
AR e31052
DI 10.1371/journal.pone.0031052
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 928WA
UT WOS:000303017700006
PM 22403609
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Rudnick, JA
   Arendt, LM
   Klebba, I
   Hinds, JW
   Iyer, V
   Gupta, PB
   Naber, SP
   Kuperwasser, C
AF Rudnick, Jenny A.
   Arendt, Lisa M.
   Klebba, Ina
   Hinds, John W.
   Iyer, Vandana
   Gupta, Piyush B.
   Naber, Stephen P.
   Kuperwasser, Charlotte
TI Functional Heterogeneity of Breast Fibroblasts Is Defined by a
   Prostaglandin Secretory Phenotype that Promotes Expansion of Cancer-Stem
   Like Cells
SO PLOS ONE
LA English
DT Article
ID SMOOTH MUSCLE ACTIN; STROMAL FIBROBLASTS; TUMOR-GROWTH;
   MICROENVIRONMENT; MYOFIBROBLASTS; GENERATION; FIBROSIS; MODEL; GLAND;
   DIFFERENTIATION
AB Fibroblasts are important in orchestrating various functions necessary for maintaining normal tissue homeostasis as well as promoting malignant tumor growth. Significant evidence indicates that fibroblasts are functionally heterogeneous with respect to their ability to promote tumor growth, but markers that can be used to distinguish growth promoting from growth suppressing fibroblasts remain ill-defined. Here we show that human breast fibroblasts are functionally heterogeneous with respect to tumor-promoting activity regardless of whether they were isolated from normal or cancerous breast tissues. Rather than significant differences in fibroblast marker expression, we show that fibroblasts secreting abundant levels of prostaglandin (PGE2), when isolated from either reduction mammoplasty or carcinoma tissues, were both capable of enhancing tumor growth in vivo and could increase the number of cancer stem-like cells. PGE2 further enhanced the tumor promoting properties of fibroblasts by increasing secretion of IL-6, which was necessary, but not sufficient, for expansion of breast cancer stem-like cells. These findings identify a population of fibroblasts which both produce and respond to PGE2, and that are functionally distinct from other fibroblasts. Identifying markers of these cells could allow for the targeted ablation of tumor-promoting and inflammatory fibroblasts in human breast cancers.
C1 [Arendt, Lisa M.; Klebba, Ina; Hinds, John W.; Iyer, Vandana; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA.
   [Gupta, Piyush B.] Massachusetts Inst Technol & Harvard, Whitehead Inst Biomed Res, Broad Inst, Dept Biol, Cambridge, MA USA.
   [Naber, Stephen P.] Tufts Med Ctr, Dept Pathol, Boston, MA USA.
RP Rudnick, JA (reprint author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Grad Program Cell,Mol & Dev Biol Program, Boston, MA 02111 USA.
EM Charlotte.Kuperwasser@tufts.edu
OI Arendt, Lisa/0000-0002-7954-3635
FU Department of Defense; Raymond and Beverly Sackler Foundation; Breast
   Cancer Research Foundation; Silvian Foundation; National Institutes of
   Health/National Cancer Institute [CA125554, CA092644]
FX This work was supported by grants from the Department of Defense Breast
   Cancer Research Program Pre-doctoral Traineeship Award (to JR), the
   Raymond and Beverly Sackler Foundation, the Breast Cancer Research
   Foundation, the Silvian Foundation, and the National Institutes of
   Health/National Cancer Institute (CA125554, CA092644; to CK). CK is a
   Raymond and Beverly Sackler Foundation Scholar. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100
   Arendt LM, 2010, SEMIN CELL DEV BIOL, V21, P11, DOI 10.1016/j.semcdb.2009.10.003
   Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960
   Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463
   Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135
   Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x
   DESMOULIERE A, 1992, EXP CELL RES, V201, P64, DOI 10.1016/0014-4827(92)90348-C
   DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389
   DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
   Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041
   Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982
   Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107
   FRIES KM, 1994, CLIN IMMUNOL IMMUNOP, V72, P283, DOI 10.1006/clin.1994.1144
   Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106
   Huang MZ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-80
   Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714
   Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108
   Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014
   Jelaska A, 1999, SPRINGER SEMIN IMMUN, V21, P385, DOI 10.1007/BF00870301
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Katoh H, 2010, AM J PATHOL, V176, P1469, DOI 10.2353/ajpath.2010.090607
   Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755
   KO SD, 1977, P NATL ACAD SCI USA, V74, P3429, DOI 10.1073/pnas.74.8.3429
   Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107
   KORN JH, 1984, ARTHRITIS RHEUM, V27, P174, DOI 10.1002/art.1780270208
   Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322
   Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965
   Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357
   Meric JB, 2006, CRIT REV ONCOL HEMAT, V59, P51, DOI 10.1016/j.critrevonc.2006.01.003
   Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217
   North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883
   Olumi AF, 1999, CANCER RES, V59, P5002
   Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034
   Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112
   Proia DA, 2005, CELL CYCLE, V4, P1022, DOI 10.4161/cc.4.8.1903
   Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31
   Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360
   Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186
   Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449
   RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736
   RONNOVJESSEN L, 1993, LAB INVEST, V68, P696
   RONNOVJESSEN L, 1990, LAB INVEST, V63, P532
   Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533
   Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002
   Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542
   Singh A, 1999, ENDOCR-RELAT CANCER, V6, P139, DOI 10.1677/erc.0.0060139
   Sotgia F, 2009, AM J PATHOL, V174, P746, DOI 10.2353/ajpath.2009.080658
   Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354
   TIPTON DA, 1991, J CELL BIOCHEM, V46, P152, DOI 10.1002/jcb.240460209
   Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486
   Trimmer C, 2011, CANCER BIOL THER, V11, P383, DOI 10.4161/cbt.11.4.14101
   Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722
   Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873
NR 57
TC 35
Z9 35
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 21
PY 2011
VL 6
IS 9
AR e24605
DI 10.1371/journal.pone.0024605
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 825HM
UT WOS:000295262100015
PM 21957456
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU O'Donovan, A
   Pantell, MS
   Puterman, E
   Dhabhar, FS
   Blackburn, EH
   Yaffe, K
   Cawthon, RM
   Opresko, PL
   Hsueh, WC
   Satterfield, S
   Newman, AB
   Ayonayon, HN
   Rubin, SM
   Harris, TB
   Epel, ES
AF O'Donovan, Aoife
   Pantell, Matthew S.
   Puterman, Eli
   Dhabhar, Firdaus S.
   Blackburn, Elizabeth H.
   Yaffe, Kristine
   Cawthon, Richard M.
   Opresko, Patricia L.
   Hsueh, Wen-Chi
   Satterfield, Suzanne
   Newman, Anne B.
   Ayonayon, Hilsa N.
   Rubin, Susan M.
   Harris, Tamara B.
   Epel, Elissa S.
CA Hlth Aging Body Composition Study
TI Cumulative Inflammatory Load Is Associated with Short Leukocyte Telomere
   Length in the Health, Aging and Body Composition Study
SO PLOS ONE
LA English
DT Article
ID C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; CALORIE RESTRICTION; HUMAN
   HEPATOCYTES; DNA-DAMAGE; MORTALITY; RISK; INTERLEUKIN-6; CANCER; CELLS
AB Background: Leukocyte telomere length (LTL) is an emerging marker of biological age. Chronic inflammatory activity is commonly proposed as a promoter of biological aging in general, and of leukocyte telomere shortening in particular. In addition, senescent cells with critically short telomeres produce pro-inflammatory factors. However, in spite of the proposed causal links between inflammatory activity and LTL, there is little clinical evidence in support of their covariation and interaction.
   Methodology/Principal Findings: To address this issue, we examined if individuals with high levels of the systemic inflammatory markers interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and C-reactive protein (CRP) had increased odds for short LTL. Our sample included 1,962 high-functioning adults who participated in the Health, Aging and Body Composition Study (age range: 70-79 years). Logistic regression analyses indicated that individuals with high levels of either IL-6 or TNF-alpha had significantly higher odds for short LTL. Furthermore, individuals with high levels of both IL-6 and TNF-alpha had significantly higher odds for short LTL compared with those who had neither high (OR = 0.52, CI = 0.37-0.72), only IL-6 high (OR = 0.57, CI = 0.39-0.83) or only TNF-alpha high (OR = 0.67, CI = 0.46-0.99), adjusting for a wide variety of established risk factors and potential confounds. In contrast, CRP was not associated with LTL.
   Conclusions/Significance: Results suggest that cumulative inflammatory load, as indexed by the combination of high levels of IL-6 and TNF-alpha, is associated with increased odds for short LTL. In contrast, high levels of CRP were not accompanied by short LTL in this cohort of older adults. These data provide the first large-scale demonstration of links between inflammatory markers and LTL in an older population.
C1 [O'Donovan, Aoife; Puterman, Eli; Yaffe, Kristine; Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.
   [O'Donovan, Aoife; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA.
   [Pantell, Matthew S.] Univ Calif Berkeley, Univ Calif, San Francisco Joint Med Program, Berkeley, CA 94720 USA.
   [Pantell, Matthew S.] Univ Calif Berkeley, Univ Calif, San Francisco Joint Med Program, San Francisco, CA USA.
   [Dhabhar, Firdaus S.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.
   [Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.
   [Yaffe, Kristine; Hsueh, Wen-Chi; Ayonayon, Hilsa N.; Rubin, Susan M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
   [Cawthon, Richard M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA.
   [Opresko, Patricia L.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA.
   [Hsueh, Wen-Chi] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Satterfield, Suzanne] Univ Tennessee, Dept Prevent Med, Memphis, TN 38163 USA.
   [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.
   [Harris, Tamara B.] NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA.
RP O'Donovan, A (reprint author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.
EM aoife.odonovan@ucsf.edu
RI Newman, Anne B./C-6408-2013
OI Newman, Anne B./0000-0002-0106-1150; Opresko,
   Patricia/0000-0002-6470-2189; Puterman, Eli/0000-0002-5898-2348
FU National Institutes of Health (NIH) National Institute on Aging (NIA)
   [AG-6-2101, AG-6-2103, AG-6-2106, AG021918]; Society in Science: The
   Branco Weiss Fellowship
FX The study was conducted on behalf of the Health, Aging and Body
   Composition (Health ABC) Study and was funded by National Institutes of
   Health (NIH) National Institute on Aging (NIA) grants AG-6-2101,
   AG-6-2103, AG-6-2106, and AG021918. This work was also supported by the
   Intramural Research Program of the NIH, NIA as well as by Society in
   Science: The Branco Weiss Fellowship (AOD). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Akiyama M, 2004, BIOCHEM BIOPH RES CO, V316, P528, DOI 10.1016/j.bbrc.2004.02.080
   AVIV A, 2004, TELOMERES HUMAN AGIN, pPE43
   Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979
   Aviv A, 2009, INT J EPIDEMIOL, V38, P1735, DOI 10.1093/ije/dyp298
   Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Calabro P, 2003, CIRCULATION, V108, P1930, DOI 10.1161/01.CIR.0000096055.62724.C5
   Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x
   CASTELL JV, 1988, FEBS LETT, V232, P347, DOI 10.1016/0014-5793(88)80766-X
   CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954
   Epel ES, 2009, AGING-US, V1, P81
   Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049
   Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI 10.1093/aje/kw346
   GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0
   Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2
   Houben JMJ, 2009, RESP MED, V103, P230, DOI 10.1016/j.rmed.2008.09.003
   Jaiswal M, 2000, CANCER RES, V60, P184
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Kinouchi Y, 1998, J GASTROENTEROL, V33, P343, DOI 10.1007/s005350050094
   Kritchevsky SB, 2005, CARDIOVASC RES, V66, P265, DOI 10.1016/j.cardiores.2004.12.026
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Lin MT, 2001, CARCINOGENESIS, V22, P1947, DOI 10.1093/carcin/22.12.1947
   MANGAN DF, 1991, J IMMUNOL, V147, P3408
   Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081
   Nishida H, 2011, CYTOKINE, V53, P342, DOI 10.1016/j.cyto.2010.12.005
   Njajou OT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013048
   Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061
   PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664
   Parish ST, 2009, J IMMUNOL, V182, P4237, DOI 10.4049/jimmunol.0803449
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P747, DOI 10.1158/1055-9965.EPT-06-0667
   Steer SE, 2007, ANN RHEUM DIS, V66, P476, DOI 10.1136/ard.2006.059188
   Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106
   Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X
   Volpato S, 2001, CIRCULATION, V103, P947
   Weinhold B, 1997, BIOCHEM J, V325, P617, DOI 10.1042/bj3250617
   Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897
   Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484
   Xu DW, 2000, BLOOD, V96, P4313
NR 52
TC 142
Z9 145
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 13
PY 2011
VL 6
IS 5
AR e19687
DI 10.1371/journal.pone.0019687
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 763LP
UT WOS:000290558500023
PM 21602933
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Coppe, JP
   Patil, CK
   Rodier, F
   Krtolica, A
   Beausejour, CM
   Parrinello, S
   Hodgson, JG
   Chin, KE
   Desprez, PY
   Campisi, J
AF Coppe, Jean-Philippe
   Patil, Christopher K.
   Rodier, Francis
   Krtolica, Ana
   Beausejour, Christian M.
   Parrinello, Simona
   Hodgson, J. Graeme
   Chin, Koei
   Desprez, Pierre-Yves
   Campisi, Judith
TI A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in
   Mouse Cells Dependent on Physiological Oxygen
SO PLOS ONE
LA English
DT Article
ID CELLULAR SENESCENCE; DNA-DAMAGE; REPLICATIVE SENESCENCE;
   HUMAN-FIBROBLASTS; GENE-EXPRESSION; IN-VIVO; TRIGGERS SENESCENCE; CANCER
   PROGRESSION; EPITHELIAL-CELLS; GROWTH-FACTOR
AB Cellular senescence irreversibly arrests cell proliferation in response to oncogenic stimuli. Human cells develop a senescence-associated secretory phenotype (SASP), which increases the secretion of cytokines and other factors that alter the behavior of neighboring cells. We show here that "senescent'' mouse fibroblasts, which arrested growth after repeated passage under standard culture conditions (20% oxygen), do not express a human-like SASP, and differ from similarly cultured human cells in other respects. However, when cultured in physiological (3%) oxygen and induced to senesce by radiation, mouse cells more closely resemble human cells, including expression of a robust SASP. We describe two new aspects of the human and mouse SASPs. First, cells from both species upregulated the expression and secretion of several matrix metalloproteinases, which comprise a conserved genomic cluster. Second, for both species, the ability to promote the growth of premalignant epithelial cells was due primarily to the conserved SASP factor CXCL-1/KC/GRO-alpha. Further, mouse fibroblasts made senescent in 3%, but not 20%, oxygen promoted epithelial tumorigenesis in mouse xenographs. Our findings underscore critical mouse-human differences in oxygen sensitivity, identify conditions to use mouse cells to model human cellular senescence, and reveal novel conserved features of the SASP.
C1 [Coppe, Jean-Philippe; Patil, Christopher K.; Rodier, Francis; Krtolica, Ana; Parrinello, Simona; Desprez, Pierre-Yves; Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.
   [Coppe, Jean-Philippe; Patil, Christopher K.; Rodier, Francis; Desprez, Pierre-Yves; Campisi, Judith] Buck Inst Age Res, Novato, CA USA.
   [Beausejour, Christian M.] Univ Montreal, CHU Ste Justine, Ctr Rech, Montreal, PQ, Canada.
   [Beausejour, Christian M.] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.
   [Hodgson, J. Graeme; Chin, Koei] Univ Calif San Francisco, Dept Lab Med, Ctr Comprehens Canc, San Francisco, CA 94143 USA.
   [Desprez, Pierre-Yves] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA.
RP Coppe, JP (reprint author), Dynam Throughput Inc, Berkeley, CA USA.
EM jcampisi@buckinstitute.org
OI Rodier, Francis/0000-0003-2523-309X
FU National Institutes of Health [AG09909, AG017242, CA126540, AG000266,
   AG0025708]; Larry L. Hillblom Foundation; California Breast Cancer
   Research Program [8KB-0100]; US Department of Energy [DE-AC03-76SF00098]
FX Supported by grants from the National Institutes of Health (research
   grants AG09909, AG017242 and CA126540 to JC; training grant AG000266;
   center grant AG0025708), Larry L. Hillblom Foundation (to CKP),
   California Breast Cancer Research Program (8KB-0100 to AK) and the US
   Department of Energy under contract DE-AC03-76SF00098 (JC). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Beliveau A, 2007, P NATL ACAD SCI USA, V104, P4431, DOI 10.1073/pnas.0700260104
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599
   Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1140/annurev-pathol-121808-102144
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118
   Di Micco R, 2008, CELL CYCLE, V7, P3601, DOI 10.4161/cc.7.22.7152
   Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010
   Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556
   Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241
   Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443
   Hampel B, 2006, EXP GERONTOL, V41, P474, DOI 10.1016/j.exger.2006.03.001
   Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   HORNSBY PJ, 2003, SCI AGING KNOWLEDGE, pPE21
   Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2002, CYTOMETRY, V49, P73, DOI 10.1002/cyto.10149
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452
   Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014
   Mason DX, 2004, ONCOGENE, V23, P9238, DOI 10.1038/sj.onc.1208172
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007
   ROBERTS S, 2006, EUR SPINE J, V15, P312, DOI DOI 10.1007/S00586-006-0126-8
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   Shay JW, 2007, CANCER CELL, V12, P100, DOI 10.1016/j.ccr.2007.07.012
   Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871
   Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200
   Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592
   Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682
   Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103
   Yaswen P, 2002, INT J BIOCHEM CELL B, V34, P1382, DOI 10.1016/S1357-2725(02)00047-X
   Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100
   Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019
NR 54
TC 188
Z9 194
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 12
PY 2010
VL 5
IS 2
AR e9188
DI 10.1371/journal.pone.0009188
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 554ZC
UT WOS:000274474600009
PM 20169192
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

EF